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ABSTRACT 
 Over forty years ago, Singer and Nicholson began studying the organization of the 
plasma membranes on mammalian cells. Since then, our understanding of this membrane has 
shifted from that of a homogeneous to a more heterogenous environment of proteins and lipids. 
The complexity of living cells have made for difficulties in obtaining a complete understanding 
of the plasma membrane, especially that of the sphingolipids’ organization. 
 The recent application of imaging mass spectrometry to biological samples has enabled 
for the chemical analysis of the plasma membrane. Through the use of a high resolution imaging 
secondary ion mass spectrometer (NanoSIMS 50, Cameca), we have been able to chemically 
map the distributions of sphingolipids on the plasma membrane of murine fibroblast cells with an 
astonishing sub-100 nm resolution. This required us to metabolically incorporate a rare, stable 
label into the molecules of interest and chemically preserving the cells in an effort to maintain 
close to a native organization of the membrane. The labeled lipid species could then be 
visualized with the NanoSIMS, providing us with a closer understanding of lipids within the 
plasma membrane. 
 These experiments have revealed that sphingolipid-enriched domains exist in the plasma 
membrane on a length scale of ~200 nm, and they form non-random clustering on the cell 
surface. Disruption of the cellular cytoskeleton resulted in a loss of detectable statistically 
significant domains. In addition, the rapid transport of sphingolipids to the plasma membrane has 
made for complex interpretation of the role that vesicle transport plays in domain formation. 
Further studies using this methodology of chemically imaging mammalian cells, most 
importantly disruption of vesicle trafficking, may help to definitively identify the mechanisms 
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behind the formation of these lipid domains as well as elucidate the full purpose they serve in the 
cell. 
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CHAPTER 1. 
INTRODUCTION
1
 
 
The Plasma Membrane 
The plasma membrane is the outermost structure of mammalian cells. It is involved in 
many key cell functions including cell-cell recognition, signal transduction, and nutrient 
uptake.
2–6
 The plasma membrane is comprised of a lipid bilayer that contains hundreds of 
different lipid species, sterols, proteins, and complex carbohydrates. Because of the membrane’s 
importance in multiple cellular processes, many studies have focused on elucidating plasma 
membrane organization and how this organization changes in response to internal and external 
stimuli, such as protein signaling, cholesterol depletion, and mutations in integral membrane 
proteins.
7–10
  
The fluid mosaic model was one of the initial guiding principles for understanding cell 
membrane organization. Singer and Nicolson described the membrane as a two-dimensional 
fluid in which components freely diffuse in the lateral direction, implying homogeneous mixing.
5
  
This concept of homogeneous mixing was contradicted by the finding that lipid composition 
within viral envelopes often differed from that of the host cell.
11
 Enveloped viruses, such as 
influenza, are coated with a portion of the host cell’s plasma membrane when they bud from the 
host cell. If the lipid composition of the host cell’s plasma membrane was homogeneous, as 
suggested by the fluid mosaic model, then the resulting viral envelope should have a more 
representative lipid composition of the host cell. Biochemical analysis, however, indicated that 
                                                          
1
 This chapter features portions of work which originally appeared in a published manuscript
1
 
and has been reprinted with permissions from: 
Molecular and Cell Biology of Lipids. Kraft, M. L.; Klitzing, H. A. Imaging Lipids with 
Secondary Ion Mass Spectrometry. Biochim. Biophys. Acta BBA - Mol. Cell Biol. Lipids 2014, 
1841 (8), 1108–1119. Both Mary L. Kraft and Haley A. Klitzing contributed to writing the 
manuscript. 
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the influenza viral envelopes are enriched with sphingolipids and cholesterol when compared to 
the bulk membrane of the host cell.
12,13
 These results, among other, have led to the hypothesis 
that there are regions within the plasma membrane, often referred to as lipid rafts, which are 
cholesterol and sphingolipid enriched.
14
 Since then, a growing body of data suggests that 
cholesterol- and sphingolipid-rich domains play important roles in many other processes, 
including protein recruitment, signal transduction, intracellular sorting, and viral entry, assembly, 
and budding.
4,6,13,15,16
 These domains are believed to form due to energetically favorable 
interactions (in the form of hydrogen bond formation) between certain membrane proteins and 
lipid species, specifically cholesterol and sphingolipids.
3,13,14,16–20
 Despite their importance, 
compositionally distinct lipid domains remain controversial because it is necessary to 
unambiguously detect /visualize these microdomains in order to test either hypothesis. 
The abundances and distributions of various lipid species within tissues and cells are 
linked to both health and disease.
21–25,25–27
 In mammalian cells, lipids are not only the building 
blocks of cellular membranes, but they also function as ligands that selectively bind to and 
regulate the activity of certain protein components in signaling pathways.
28–37
 This is especially 
true of sphingolipids, as ceramide, the product of sphingomyelin hydrolysis, is involved in the 
signaling pathways that regulate apoptosis, cytoskeletal reorganization, and other important 
cellular processes.
23,38–41
 
The three most prominent hypotheses for sphingolipid domain formation in the plasma 
membrane involve protein-lipid interactions, intracellular transport of materials to the cell 
surface, and diffusional barriers due to the cell’s actin cytoskeleton. As mentioned above, the 
protein-lipid interaction hypothesis suggests that certain membrane proteins and specific lipid 
species, namely sphingolipids and cholesterol, have energetically favorable interactions that 
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result in the formation of compositionally distinct lipid microdomains.
3,13,14,16–20
 Second, the 
intracellular transport of vesicles composed of newly synthesized sphingolipids and membrane 
proteins to the cell surface is hypothesized to result in membrane domains that are enriched with 
the vesicle’s cargo. The lifetime of the resulting compositionally distinct lipids domains may be 
very short unless the lateral diffusion of lipid components away from the fusion site is 
obstructed.
3,9,16,42–44
 The third hypothesis for compositionally distinct membrane domain 
formation involves the cellular cytoskeleton, which is the protein network that underlies the 
plasma membrane. The cytoskeleton is composed of actin filaments, and it gives the cell its 
shape and support, assists in cell movement, and participates in creating cell-cell junctions.
45,46
 
The actin cytoskeleton is hypothesized to hinder the lateral diffusion of proteins and lipids within 
the plasma membrane, and thereby stabilize compositionally distinct lipid microdomains that 
form in the plasma membrane due to membrane trafficking or selective protein-lipid or lipid-
lipid interactions.
2,16,19,42,46–49
 When the research reported in this thesis was initiated, there is no 
consensus on the extent to which each mechanism contributes to lipid domain formation, as the 
indirect methods used to detect lipid domains have produced various and often conflicting 
results.  
Imaging Lipid Distribution in Membranes 
Insight into lipid metabolism, transport, and function has been acquired by studying their 
distributions within tissues and cells. The locations and abundances of various lipid species are 
often probed by using fluorescent lipid analogs, lipophilic dyes, or lipid-specific functionalized 
antibodies that can be detected with light, fluorescence, or electron microscopy.
50–54
 The 
distributions of various lipid species in biological samples can also be mapped with high 
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chemical specificity and without the use of complex labels, such as fluorophores or antibodies, 
with imaging mass spectrometry. 
Matrix-assisted laser desorption ionization (MALDI) is perhaps the most popular imaging 
mass spectrometry technique that has been used to analyze biological samples. As the name 
implies, the sample is coated with a matrix that promotes biomolecule desorption and ionization, 
and a laser is used to ionize the molecules within its focal area. This ionization process 
minimizes molecular fragmentation, enabling the detection of molecular ions with high mass-to-
charge ratios (m/z 500–20,000).55,56 MALDI has been used to image a wide range of 
biomolecules, including lipids and proteins, with a lateral resolution that is typically > 10 μm and 
a sampling depth in the micron range.
56–61
 This spatial resolution renders MALDI imaging 
appropriate for analyzing the lipid distributions within tissues. MALDI imaging of biomolecules, 
including lipids, in tissues has been the subject of recent reviews
55,57,62–64
 and will not be 
discussed further herein. 
This dissertation will focus on a complementary imaging mass spectrometry technique, 
secondary ion mass spectrometry (SIMS). SIMS offers higher spatial resolution than MALDI, 
but typically at the expense of higher molecular fragmentation, which results in lower chemical 
specificity. SIMS can achieve the sub-micrometer lateral resolution that enables studying the 
lipid distribution within a single cell. Moreover, the analysis depth of SIMS is ultimately limited 
by the escape depth of the secondary ions, which is generally limited to the upper one to two 
monolayers of the sample.
65
 Thus, when performed at the surface of the sample, SIMS has the 
shallow sampling depth (top ≤ 5 nm) that permits imaging the lipids in the plasma membrane 
with little interference from intracellular membranes. 
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SIMS Techniques 
SIMS imaging of lipids has been primarily performed using two different types of 
instrumentation, time-of-flight SIMS (TOF-SIMS) and magnetic sector SIMS with high lateral 
resolution. Both TOF-SIMS and high-resolution magnetic sector SIMS are performed under 
ultra-high vacuum (UHV), which is the techniques' greatest limitation. During analysis, a 
focused primary ion beam sputters neutral and ionized molecules and molecular fragments from 
the surface of the sample. This primary ion beam is scanned across the sample, and the 
secondary ions that are ejected at each beam position are collected. The intensities of the 
secondary ions that are characteristic of specific components are then used to create a map of that 
component's distribution on the surface of the sample. Additionally, because material is sputtered 
from the surface of the sample during SIMS analysis, maps of component distribution at 
progressively increasing depth in the sample can be generated by repeatedly acquiring SIMS 
images at the same sample location. When depth profiling is performed with TOF-SIMS, a 
sputtering scan that removes the damaged material is often inserted after each imaging scan in 
order to reduce the fragmentation of the species detected during image acquisition. 
The intensities of the secondary ions detected at each pixel are affected by the 
concentration of the parent molecule that produced the secondary ions, as well as by 
concentration-independent factors.
66–74
 The first concentration-independent factor, which is 
referred to as matrix effects, arises because the local chemical environment affects the 
probability that a species will become ionized.
66–71
 The second concentration-independent factor 
is sample topography; differences in the incidence angle of the primary ion beam affect both the 
absolute and relative intensities of the ions.
72,73
 These concentration-independent variations in 
ion intensity complicate quantitatively imaging lipid distribution with either TOF-SIMS or high-
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resolution magnetic sector SIMS. Normalization methods have been developed to minimize 
these concentration-independent variations and produce a SIMS signal whose intensity is 
proportional to the concentration of the analyte. TOF-SIMS and high-resolution magnetic sector 
SIMS instruments differ in the configurations of their ion optics, primary ion sources, and mass 
analyzers (Table 1.1). These differences impart each approach with complementary strengths and 
weaknesses. In the following sections, a closer look will be taken of these imaging methods. 
TOF-SIMS 
TOF-SIMS instruments typically employ a pulsed primary ion beam that is oriented with 
oblique incidence to the plane of the sample.
62
 The secondary ions that are ejected from the 
sample are then collected by a TOF mass analyzer that generates a mass spectrum at each pixel. 
The spectra can have a mass range of 1 to 1500 m/z, but the ion counts generally decrease with 
increasing mass due to fragmentation. Variations in the secondary ion signal intensity that are 
caused by matrix effects and sample topography can be reduced, but not eliminated, by 
normalizing the counts of the signal of interest to that of an abundant ion or all of the ions 
detected at the same pixel.
75,76
 The collection of a mass spectrum at every pixel is advantageous 
because it negates the need for labels, as any unlabeled molecule that produces secondary ions 
with distinctive m/z can be detected and imaged. Other advantages are that multiple components 
of interest can be imaged in parallel, and the spectra contain information about both known and 
unknown components that are present in the sample. 
The lateral resolution of any SIMS technique is ultimately limited by the diameter of the 
primary ion beam, which can be 200 nm or less, depending on the instrument. However, for 
imaging lipids with TOF-SIMS, the working lateral resolution is often larger than the beam 
diameter because the numbers of lipid-specific secondary ions detected at each beam position are 
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insufficient for resolving features in an image.
77
 Therefore, TOF-SIMS analyses must be 
optimized to increase the ejection of secondary ions that are characteristic of each lipid species 
of interest. Intact molecular ion species are most useful for this purpose. To maximize the 
detection of intact molecular ions and reduce the ejection of fragment ions from the sample, the 
amount of chemical damage at the surface of the sample must be minimized. Note that the term 
chemical damage is used to refer to molecular fragmentation, and does not refer to structural 
reorganization at length scales that are accessible to detection with SIMS. A common approach 
for minimizing molecular fragmentation is to limit the primary ion dose so that each primary ion 
impacts a pristine region on the sample, and not a region where the molecules were already 
fragmented by collision with a primary ion
78,79
 This is referred to as static SIMS analysis, where 
the static limit is typically estimated to be below 10
13
 ions/cm
2
.
79,80
 Even when TOF-SIMS is 
performed under static conditions, molecular fragmentation can limit the selectivity and working 
lateral resolution of lipid imaging. When this occurs, fragment ions that are common to multiple 
species from a common lipid class, such as the phosphocholine headgroup-containing ions at m/z 
184 [C5H15NPO4]
+
 and 224 [C8H19NPO4]
+
, can be detected to achieve a working lateral 
resolution ≤ 1 μm.76,81,82 However, lipids from the same class cannot be discriminated by these 
fragment ions. Several strategies have been developed to increase the detection of secondary ion 
signals that are useful for lipid identification including the use of cluster ion sources,
71–84
 
processing with multivariate analysis techniques,
83–102
 and the use of MALDI matrices.
103–109
  
Given the current capabilities of TOF-SIMS, this approach is most advantageous for 
detecting, identifying, and imaging multiple unlabeled lipids, including those with unknown 
structures, within tissues. TOF-SIMS imaging of lipids in individual cells is possible, though 
detection is now typically limited to the most abundant lipid species and a lateral resolution 
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≥ 1 μm. This lateral resolution was not expected to be sufficient for assessing cholesterol and 
sphingolipid distribution in the plasma membrane, so we opted for the following approach. 
High-Resolution Magnetic Sector SIMS Performed with a Cameca NanoSIMS 50 
An alternative strategy to overcoming the low yields of component-specific secondary 
ions that limit the working lateral resolution is to exploit the higher-yielding monoatomic and 
diatomic ions for component detection. This strategy is implemented in a commercial magnetic 
sector SIMS instrument, the Cameca NanoSIMS 50(L). SIMS performed with this instrument is 
often referred to as high-resolution SIMS or NanoSIMS. 
The NanoSIMS differs from conventional TOF-SIMS instruments in a few ways. First, it 
reveals the elemental and isotopic compositions in a sample by detecting monoatomic and 
diatomic secondary ions, which have higher yields than the molecular ions and high mass 
fragment ions used for TOF-SIMS analysis. Second, the NanoSIMS employs co-axial optics to 
direct the primary and secondary ions, which must have opposite polarities. The advantage of the 
co-axial configuration is it enables a shorter working distance, which simultaneously enhances 
focusing the reactive primary ions (Cs
+
 or O
−
) onto the sample and extracting the resulting 
secondary ions (Fig. 1.1). Instead of acquiring a complete mass spectrum, monoatomic and 
diatomic secondary ions with up to five or seven (depending on the NanoSIMS model) different 
m/z ratios are detected in parallel by a magnetic sector mass spectrometer that can differentiate 
isobars of the same nominal mass (i.e., 
12
C
15
N
−
, 26.9996 amu; and 
13
C
14
N
−
, 27.0059 amu can be 
separated). The intensities of the ions detected at each beam position are used to construct a map 
of the elemental and isotopic compositions of the sample's surface. The microcesium primary ion 
source developed by Cameca enables imaging negative secondary ions with a lateral resolution 
as good as 30 nm.
110
 However, the working lateral resolution achieved for imaging lipids in 
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membranes is typically around 100 nm due to the relatively low secondary ion counts obtained 
when biological samples are analyzed with small diameter primary ion beams that have low 
currents.  
Because monoatomic and diatomic secondary ions are collected by the NanoSIMS, the 
molecules of interest must contain a distinct element or isotope so that they produce elementally 
or isotopically distinct secondary ions that can be used for component identification.
111,112
 To 
detect and image lipids, labeling with distinct stable isotopes is advantageous because the 
isotope-labeled lipid has the same chemical structure as the unlabeled native lipid molecule. This 
helps to ensure that the labeling will not alter the molecular interactions or intracellular 
trafficking that may contribute to lipid distribution in the sample. For studies of model lipid 
membranes, lipids that contain stable isotope labels can be obtained from commercial sources or 
synthesized with chemical methods. To image specific lipid species within cellular membranes, 
metabolic labeling must be used to selectively incorporate distinct stable isotopes into the lipid 
species of interest within living cells. 
NanoSIMS instruments are optimized for imaging with at high primary ion doses 
(> 10
15
 ions/cm
2
) that erode the sample surface. This mode of operation, which is called dynamic 
SIMS, enables the rapid acquisition of depth profiles. However, for the analysis of lipid 
distribution in the plasma membrane, the vast majority of secondary ions that are collected from 
the surface of the cell must be produced by the cell membrane, and few secondary ions should be 
collected from the underlying cytoplasm. This necessitates restricting the sputtering depth so it is 
less than the thicknesses of the plasma membrane (7.5 nm).
113
  
The lateral resolution, sensitivity, and need for elemental or distinctive isotope-labels for 
lipid identification render NanoSIMS most advantageous for imaging a small number of known 
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lipid targets that can be metabolically or chemically labeled with stable isotopes, and high 
(~ 100 nm) lateral resolution is required. Its primary drawbacks are the need for isotope labels, 
only a limited number of lipid species can be imaged in parallel, and the cost of the NanoSIMS 
50(L) instrument limits its availability.  
The work described in this dissertation relates to the development and use of NanoSIMS 
techniques for studying lipids and their formation of domains in the plasma membrane. 
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Figures and Tables 
 
 
 
Table 1.1  Comparison of SIMS approaches. 
  
TOF-SIMS NanoSIMS
Lateral resolution ≥ 500 nm ≥ 100 nm
Information Molecular Elemental & isotopic
Typical strategy for lipid 
identification
m/z  of ions is characteristic to the 
component of interest
Isotope labeling is used to encode the 
lipid species of interest with a distinctive 
isotope signature
Primary ion source Cluster ion sources (C60+, Bi3+, Au3+, SF5+) Cs or oxygen
Mass analyzer TOF Magnetic sector
Secondary ion size Molecular & high mass fragments Monotomic & diatomic
Number of collected ions Entire spectra 5–7 different m/z ratios
Requires a priori selection of 
target component(s)?
No Yes
Unique capabilities Identification of unknown lipid structures 
at specific locations in tissues; imaging 
unlabeled lipids with moderate (≥ 1 μm) 
lateral resolution
Imaging known lipids of interest within 
model or cellular membranes with high (~ 
100 nm) lateral resolution
Major challenge Low yields of intact molecular 
ions<comma> interpretation of the mass 
spectra
Selective incorporation of distinct 
isotopes or elements into specific lipid 
species
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Figure 1.1 Schematic of the Cameca NanoSIMS 50. An oxygen or cesium primary ion beam is 
focused onto the sample. Positive or negative secondary ions, respectively, are collected by 
coaxial optics. Monoatomic and diatomic secondary ions with up to five different m/z ratios can 
be collected in parallel by the magnetic sector. 
Reproduced with permission from Annu. Rev. Biophys. 38 (2009) 53–74. 
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CHAPTER 2. 
DEVELOPMENT OF HIGH-RESOLUTION SECONDARY ION MASS 
SPECTROMETRY TECHNIQUES FOR THE VISUALIZATION OF SPHINGOLIPIDS 
ON PLASMA MEMBRANES 
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Introduction 
The distributions of cholesterol and specific lipid species within the plasma membrane 
are hypothesized to be linked to cellular function. However, characterizing the lateral variations 
in lipid abundance within biological membranes is especially challenging because few 
techniques provide the location-specific compositional information that is required for 
conclusive identification. Imaging secondary ion mass spectrometry (SIMS) offers a direct 
approach to imaging the lipid distribution within biological membranes in a chemically specific 
manner. In this method, a primary ion beam is used to produce neutral and ionized molecules and 
molecular fragments from the sample surface. The ionized species, which are called secondary 
ions, are analyzed in a mass spectrometer, providing chemical information about the molecules 
located within the primary beam. By scanning a focused primary ion beam across the sample and 
collecting the secondary ions, the intensities of the component-specific secondary ions detected 
at each position can be used to construct a map of the sample’s surface composition. Several 
different approaches have been used to image lipid membranes with SIMS.
2–10
 This chapter will 
focus on the use of high-resolution SIMS performed with a Cameca NanoSIMS 50 or 50 L. The 
NanoSIMS provides the optimum combination of spatial resolution, mass resolution (mass 
specificity), and ion transmission (sensitivity) for these experiments. Its short-comings are that a 
limited number of species can be detected simultaneously, and isotopic labels are necessary to 
distinguish most cellular molecules.  
Proper preparation of biological membranes is critical for NanoSIMS analysis. Distinct 
stable isotopes or nonnative elements must be substituted into each molecule of interest so that 
the monatomic and small molecular secondary ions generated during NanoSIMS analysis can be 
linked to a specific parent molecule. In addition, biological samples must also be preserved so 
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that the membrane retains its organization when subjected to the ultrahigh vacuum conditions 
within the NanoSIMS analysis chamber. Although NanoSIMS is not performed on living cells, it 
has advantages that are complementary to many techniques that can be performed on living cells, 
including fluorescence microscopy including: chemically specific information is used to directly 
visualize the lipid organization; isotope-labeled lipids have the same chemical structure as the 
analogous native lipid molecule, so the isotope labels do not alter the lipid distribution; analysis 
can be restricted to the outermost 1 to 2 monolayers (≤5 nm) at the sample surface;11 and a lateral 
resolution of 30 nm can be achieved with optimization meaning approximately 100 nm lateral 
resolution is routinely acquired on biological membranes.
5,8
 
This chapter describes the basic principles of assessing the distribution of a specific lipid 
species in the plasma membranes of intact cells with NanoSIMS. As an example, the sample 
preparation, NanoSIMS imaging, and image analysis required to image the distribution of 
sphingolipids and all cellular lipids (i.e., sphingolipids and glycerolipids) within the plasma 
membrane of intact mouse fibroblast cells is described. These protocols and methodologies can 
be extended to imaging other lipid species or cholesterol within the plasma membrane of various 
types of cells. The new understanding of cholesterol and sphingolipid distribution within the 
plasma membrane that we have obtained with this approach is described in subsequent chapters. 
Materials and Methods 
Preparation of Cell Substrates 
The 5 mm × 5 mm silicon chips (Ted Pella) were lightly scratched to produce an 
asymmetric pattern.  The silicon chips were then washed with soap and thoroughly rinsed with 
water to ensure the removal of any traces of soap. The chips were then sterilized by autoclaving. 
After sterilization, the surface of the chips were covered with a sterile poly-L-lysine, generated 
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by passing it through a 0.22 μm syringe driven filter unit and depositing the effluent directly onto 
the sterile chips (Electron Microscopy Sciences). 
Preparation of 
15
N-Sphingoid Bases 
The 
15
N-sphingoid bases, 
15
N-sphingosine and 
15
N-sphinganine, were synthesized from 
15
N-serine following reported methods.
12–16
 The 
15
N-sphingoid bases were dissolved in DMSO to 
make a 6 mM stock solution, which was sterilized by filtering through a DMSO-rinsed, syringe 
driven, sterile 0.2 μm PTFE filter unit. Sterile aliquots of 15N-sphingoid bases were stored at 
−20°C, and warmed to room temperature before use. 
Preparation of 
13
C-Fatty Acids 
A 1 mL stock solution of the fatty acid mixture was made by weighing out 13.3 mg of 
uniformly carbon-13 labeled algal lipid mixture (UL-
13
C-algal lipids, 98%+) (Cambridge Isotope 
Laboratories, Inc.) into a microfuge tube. The outside of a hayman style microspatula scoop was 
used to obtain small portions of the lipid mixture that were deposited into the microfuge tube by 
wiping. We then added 3.3 mg of 
13
C18-stearic acid (99 atom% 
13
C) (Isotec) to a separate 
microfuge tube. Next, 125 mg of fatty acid free bovine serum albumin (BSA) (Sigma) and 1 mL 
of Dulbecco’s phosphate-buffered saline (PBS) were added to a third microfuge tube, and 
dissolved by vortexing. Remaining large crystals were dissolved by briefly centrifuging for a few 
seconds. Once fully dissolved, the BSA was sterile filtered through a syringe driven, 0.22 μm 
PVDF filter unit that had been rinsed with PBS, and collected in a sterile microfuge tube. The 
filter unit was air-purged to ensure a quantitative transfer. To the microfuge tube containing the 
algal lipid mixture, 250 μL of DMSO was added and vortexed to dissolve. The dissolved UL-
13
C-algal lipid mixture was quantitatively transferred into the microtube containing the 
13
C18-
stearic acid, and vortexed. The solution was then sonicated in a bath sonicator until all of the 
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crystals were dissolved. The UL-
13
C-algal lipid/
13
C18-stearic acid mixture was sterile filtered 
using a pre-DMSO-rinsed, syringe driven, 0.2 μm PTFE filter unit that had been air-purged to 
ensure quantitative transfer. To this sterile 250 μL solution, 750 μL of the sterile BSA solution 
was added. The BSA/ UL-
13
C-algal lipid/ 
13
C18-fatty acid mixture was vortexed and sonicated for 
15 min to dissolve all the precipitate. This resulted in a 1 mL stock solution that had a 
concentration of 16.6 mg/mL, or approximately 0.0556 M. This solution was stored at 4°C. Prior 
to use, the stock solution was warmed to room temperature and thoroughly mixed by vortexing. 
Cell Culture 
NIH3T3 (ATCC CRL-1658
TM
) and a NIH3T3 transfected mouse fibroblast cell line that 
stably expresses influenza hemagglutinin (Clone 15 cell line) were grown in high glucose 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% Hyclone calf serum, 
10
4
 U/mL penicillin G, and 10 mg/mL streptomycin (Media A) for 1 passage (3 days) at 37°C in 
5% CO2. Each day, the stock solution of 
15
N-sphingoid bases was added via pipette to maintain a 
15
N-sphingoid base concentration of 3 μM. It was assumed that all of the 15N-sphingoid bases 
added to the medium were consumed within 24h.  After 3 d, the cells had reached approximately 
80% confluence and were passaged into new culture dishes that contained high glucose DMEM 
supplemented with 10% Hyclone lipid-reduced fetal bovine serum and 1% Hyclone calf serum 
(Media B) at 37°C in 5% CO2. The stock solutions of 
15
N-sphingoid bases, 
13
C-fatty acids, and 
ethanolamine were was added via pipette each day to maintain concentrations of 3 μM, 215 μM, 
and 2 μM, respectively, where all of these supplements were assumed to have been completely 
consumed after 24h. On the sixth day, the cells were passaged and reset with fresh Media B and 
supplements in dishes that also contain sterilized and poly-L-lysine-coated silicon chips. The 
cells were collected on the 7th day. 
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Collection of Samples 
Silicon chips with attached cells were removed from the dishes and set aside for chemical 
fixation. All cells remaining on the dish were detached and collected in a centrifuge tube. Cells 
were pelleted by centrifuging for 5 min at 201 × g. All but approximately 0.5 mL of the 
supernatant was removed from the cell pellet to ensure that the cell pellet did not dry out. To 
wash the pellet, 10 mL of PBS was added to the cells, the cells were collected by centrifugation, 
and all but 0.5 mL of PBS was decanted from the pellet.  After repeating this process twice, the 
cells were spun down, the excess PBS removed, and the cells were stored at −20°C until label 
incorporation was evaluated. 
Lipid Extraction 
The methods for lipid extraction were modified from the method of Bligh and Dyer.
17
 To 
each cell pellet, 2 mL methanol and 1 mL chloroform were added. If there was no PBS 
remaining on the cell pellet, 0.8 mL of water was also added. The pellet was then vortexed and 
sonicated to break it apart and mix thoroughly before sitting at room temperature for 1 h. The 
pellet was then centrifuged at 1,811 × g for 5 min. The liquid supernatant was decanted into a 
new centrifuge tube, leaving behind the cell pellet. To the supernatant, 1 mL of chloroform and 1 
mL of water were added, followed by vortexing and centrifugation at 1,811 × g for 5 min. The 
lower, chloroform layer was then transferred into a new vial and dried down under a stream of 
nitrogen gas. The crude lipid extracts were dissolved in 100 μL methanol and then centrifuged at 
17, 562 × g for 5 min. An injection of 4 μL of this supernatant was used for high performance 
liquid chromatography (HPLC-MS) analysis of 
15
N-incorporation. 
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Evaluation of Nitrogen-15 Incorporation into Cellular Sphingolipids 
The nitrogen-15 incorporation into the cellular sphingomyelin was analyzed with an 
Agilent 1100 LC/MSD Trap XCT Plus equipped with a Phenomenex Gemini 3u C6-Phenyl 
110A column (2  ×  100 mm). The separation was performed using methanol at a flow rate of 
300 μL/min. The following mass peaks were monitored (retention time was 1.5 min for the stated 
instrument): m/z 703.6 (unlabeled N-palmitoyl sphingomyelin), 704.6 (
15
N-palmitoyl 
sphingomyelin), 719.6 (
14
N-palmitoyl 
13
C16-sphingomyelin), 720.6 (
15
N-palmitoyl 
13
C16-
sphingomyelin), and 735.7 (
14
N-palmitoyl 
13
C32-sphingomyelin). For the cell lines used, no 
significant signal was detected for other sphingolipid species. The contribution of N-palmitoyl 
sphingomyelin isotopologues other than 
15
N-palmitoyl sphingomyelin from peak m/z 704.6 was 
removed by subtracting 43.3% of the intensity of the N-palmitoyl sphingomyelin peak (m/z 
703.6) from that of peak m/z 704.6. The contribution of sphingomyelin isotopologues other than 
15
N-palmitoyl 
13
C16 sphingomyelin to peak m/z 720.6 was removed by subtracting 25.8% of the 
intensity of the 
14
N-palmitoyl 
13
C16 sphingomyelin peak at m/z 719.6 from that of peak m/z 
720.6. The fraction of N-palmitoyl sphingomyelin that contained a nitrogen-15 isotope was 
calculated as the ratio of the sum of 
15
N-palmitoyl sphingomyelin and 
15
N-palmitoyl 
13
C16-
sphingomyelin peak intensities to the sum of the peak intensities from all N-palmitoyl 
sphingomyelin isotopologues. The fraction of N-palmitoyl sphingomyelin that biosynthesized 
from uniformly labeled 
13
C-palmitic acid was calculated as the ratio of the sum of 
14
N-palmitoyl 
13
C16-sphingomyelin, 
15
N-palmitoyl 
13
C16-sphingomyelin, and 
14
N-palmitoyl 
13
C32-
sphingomyelin, over the sum of the peaks produced by all N-palmitoyl sphingomyelin 
isotopologues. 
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Evaluation of Carbon-13 Incorporation into All Cellular Lipids 
To the crude lipid extracts after LC-MS analysis, 2.5 mL of 95% ethanol and 50 μL of 
33% KOH (w/v) was added, and the sample incubated at 70°C for 90 min. The solution was 
cooled to room temperature, transfered to a centrifuge tube, and 3 drops of concentrated HCl was 
added. Next, 5 mL of hexane was added, and the sample was vortexed and centrifuged at 1,811 × 
 g for 5 min. The upper, hexane layer was transferred to a new vial and dried down under a 
stream of nitrogen gas. The sample was resuspended in 100 μL of MeOH:CH2Cl2 (1:1), 20 μL of 
a 2 M solution of trimethylsilyldizomethane in hexane was added, and it was incubated for 1 h at 
room temperature. Gas chromatography-mass spectrometry (GC-MS) was performed on the 
resulting solution of fatty acid methyl esters (FAMEs) using an Agilent 6890 gas chromatograph 
with a ZB-WAX (30 m  ×  0.25 mm I.D., 0.25 μm film thickness) capillary column 
(Phenomenex, USA), an Agilent 5973 mass selective detector and HP 7683B (Agilent Inc, USA) 
autosampler. The inlet and MSD interface temperatures were set to 250°C, and the ion source 
temperature to 230°C, and a constant flow rate of 1.3 mL/min was used for the helium carrier 
gas. In positive electron impact mode (EI), the signal intensities corresponding to the FAMEs of 
13
C16-palmitic acid (m/z 286), 
12
C16-palmitic acid (m/z 270), 
13
C16-palmitoleic acid (m/z 284), 
12
C16- palmitoleic acid (m/z 268), 
13
C18-stearic acid (m/z 316), 
12
C18-stearic acid (m/z 298), 
13
C18-
oleic acid (m/z 314), 
12
C18-oleic acid (m/z 296), 
13
C18-linoleic acid (m/z 312), and 
12
C18-linoleic 
acid (m/z 294) were collected. These intensities were then correlated to determine a 
representative incorporation value. 
Cell Preservation with Chemical Fixation 
Silicon chips with adherent cells were removed from cell culture and rinse three times 
with Hendry’s Phosphate Buffer (HPB) for 3 min each. Care was taken as not to disturb the 
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attached cells. The chips were then flooded with 4% glutaraldehyde in HPB and allowed to fix 
for 30 min. The glutaraldehyde fixative was then removed, and the chips were rinsed twice with 
HPB for 5 min each, followed by rinsing once with water for 5 min. Chips were then further 
fixed and stained with freshly diluted, freshly filtered 1% osmium tetroxide for 15 min. After the 
removal of the osmium tetroxide, the chips were rinsed three times for 5 min each with water. 
Excess water was then removed, and the samples were to air dried followed by storage at room 
temperature. 
NanoSIMS Imaging of Cells 
Samples were coated with ~3 nm of iridium (99.95% Ir) to prevent charging during SIMS 
analysis. SIMS was performed on a NanoSIMS 50 (Cameca) at Lawrence Livermore National 
Laboratory with a 0.14 pA, 15 keV 
133
Cs
+
 primary ion beam with a beam size of ~70-nm. Four 
replicate scans of 512 x 512 pixels were performed over a 15 µm x 15 µm analysis region using 
a dwell time of 1 ms/pixel resulting in an ion dose of 4.1 × 10
14
 ions/cm
2
.  
Data Analysis 
 The collected NanoSIMS data were processed using a custom software package 
(LIMAGE; L.R. Nittler, Carnegie Institution of Washington) that runs on the PV-Wave platform 
(Rogue Wave Software). Isotope enrichment images were constructed by taking the ratio of the 
heavy isotope ion and the light isotope ion (
13
C
1
H
−
/
12
C
1
H
−
 and 
15
N
12
C
−
/
14
N
12
C
−
) followed by 
dividing the resulting ratio by the standard natural abundance ratios (0.011237 and 0.00367, 
respectively). To minimize noise in the images, a 3 by 3- pixel moving average smoothing 
algorithm was used during image construction. The MATLAB Statistics Toolbox was the used to 
determine any local elevations of statistical significance. 
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Results 
Metabolic Labeling of Cells 
To visualize specific molecules in the plasma membrane, a distinct stable isotope must be 
incorporated into the target molecules in the cell. This can be achieved with metabolic labeling. 
The general approach was to culture the cells in the presence of the isotope-labeled precursors, 
which are metabolized and integrated into the cells’ infrastructure. Methods have been 
established to selectively incorporate distinct stable isotopes or radiolabels into specific lipid 
species, including phosphatidylethanolamine,
18
 cholesterol,
19–21
 sphingolipids,
22–24
 and 
gangliosides.
25
 These methods must be optimized so that a high fraction of the lipid species of 
interest within the cell contains the distinct isotope, as the isotope enrichment image will reveal 
the location and density of only the labeled lipids.  
The selection of the distinct isotope label will influence NanoSIMS detection. Species 
with high ionization probability (i.e., CN
−
, F
−
, O
−
, and S
−
) can be detected the most efficiently. 
For the detection of species with lower ionization probabilities (i.e., CH
−
 and C
−
), a high fraction 
of the abundant isotope should be replaced with the rare isotope (i.e., the use of 
13
C16-palmitic 
acid is more desirable than 
13
C2-palmitic acid). Here, we describe how to prepare isotope-labeled 
cells for analysis with a Camecan NanoSIMS.  This includes the metabolic incorporation of 
15
N 
into the majority of the cellular sphingolipids, and 
13
C into the majority of cellular lipids. 
To facilitate imaging the same cells with multiple imaging techniques an asymmetric 
pattern was lightly scratched onto the 5 mm × 5 mm silicon chips that are used to support the 
cells. . Prior to using the patterned chips, they must be washed with soap and water, rinsed well 
with water to remove any traces of soap, and sterilized by autoclaving. Then to promote cell 
adhesion, the surfaces of the sterilized chips were covered with a sterile poly-L-lysine solution. 
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We have found that a satisfactory poly-L-lysine layer was produced by incubating the sterile 
poly-L-lysine solution with the chips at 4 °C overnight. Satisfactory results may also be obtained 
with other temperatures and incubation times. 
The 
15
N-sphingoid bases, 
15
N-sphingosine and 
15
N-sphinganine, that were metabolically 
incorporated into the cells can be synthesized from 
15
N-serine following reported methods.
12–16
 
Deuterated sphingosine (Avanti Polar Lipids) can be used in its place, and 
12
C
2
H
−
 and 
12
C
1
H
−
 
secondary ions can be collected with the NanoSIMS for the detection of the deuterated 
sphingolipids. However, we have not evaluated the intensity of the secondary ions that are 
specific to the deuterated sphingolipids. We use a 6 mM stock solution of the 
15
N-sphingoid 
bases dissolved in DMSO for metabolic labeling.  This stock solution must be sterilized by 
filtering it through a pre-DMSO-rinsed, syringe driven, sterile 0.2 μm PTFE filter unit, and 
stored at −20°C. To reduce the time required to warm the solution to room temperature prior to 
use and limit the number of times that the stock solution was thawed and refrozen, the sterile 
stock solution should be stored as ~1 mL aliquots in sterile 1.7 mL microfuge tubes.. 
The stock 
13
C-fatty acid solution that we use to incorporate carbon-13 into all cellular 
lipids consists of uniformly carbon-13 labeled algal lipids (13.3 mg/mL), 
13
C18-stearic acid (3.3 
mg/mL), and BSA (125 mg/mL) in PBS.  Due to the low solubility of the fatty acids in aqueous 
mediums, 
13
C-fatty acid and BSA solutions were prepared and sterilized separately, and then 
combined to create the stock solution that was used for metabolic labeling.  To prepare the 
13
C-
fatty acid solution, the 
13
C-fatty acids were dissolved in DMSO (250 μL per 16.6 mg fatty acid) 
and sterile filtered through a pre-DMSO-rinsed, syringe driven, 0.2 μm PTFE filter unit that was 
air-purged to ensure quantitative transfer. The BSA solution was prepared by dissolving the BSA 
in PBS (125 mg/mL) and sterile filtering it into a sterile microfuge tube using a syringe driven, 
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0.22 μm PVDF filter unit that had been rinsed with PBS. Finally, 250 μL of the sterile 13C-fatty 
acid solution was combined with 750 μL of the sterile BSA solution, mixed with a vortexer, and 
sonicated for 15 min, or until any visible precipitate dissolves. The resulting 1 mL stock solution 
has a concentration of 16.6 mg/mL, or approximately 0.0556 M. This solution was used to 
achieve the desired concentration in the cell culture media and was stored at 4°C. This stock 
solution must be warmed to room temperature and thoroughly mixed by vortexing prior to 
subsequent use. 
Cell lines used in these studies included NIH3T3 (ATCC CRL-1658
TM
) and a NIH3T3 
transfected mouse fibroblast cell line that stably expresses influenza hemagglutinin (Clone 15 
cell line). Note that other cell lines can follow similar procedures for metabolic labeling, but 
adjustments in the labeling conditions (concentrations, labeling period, media, etc.) may be 
required to obtain high levels of isotope incorporation. First, to metabolically incorporate 
nitrogen-15 into the cellular sphingolipids, the cells were grown in media that contains 3 μM of 
15
N-sphingoid bases for 1 passage (3 days). We assume that all of the 
15
N-sphingoid bases were 
consumed within 24 h, so the stock 
15
N-sphingoid base solution was added daily to maintain a 3 
μM concentration in the culture.  The cells should reach approximately 80% confluence on day 
3, at which point they were ready to be passaged into new medium (Medium B) designed for the 
metabolic incorporation of nitrogen-15 into cellular sphingolipids and carbon-13 into all cellular 
lipids. This medium contained high glucose DMEM supplemented with serum (10% Hyclone 
lipid-reduced fetal bovine serum and 1% Hyclone calf serum) 
15
N-sphingoid bases, 
13
C-fatty 
acids, and ethanolamine (3 μM, 215 μM, and 2 μM respectively). Noteworthy, lipid-reduced fetal 
bovine serum was employed because calf serum contains fairly higher levels of unlabeled 
(natural abundance) lipids that compete with the 
13
C-labeled fatty acids for incorporation into 
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cellular lipids. A small amount of calf serum was included because the cells grew poorly without 
it. Stock solutions of 
15
N-sphingoid bases, 
13
C-fatty acids, and ethanolamine were added every 
24 h to maintain concentrations of 3 μM, 215 μM, and 2 μM, respectively, in the culture. On the 
sixth day, cells are passaged into new dishes containing fresh Media B and sterilized and poly-L-
lysine-coated silicon chips. The silicon chips with attached cells are collected on the 7
th
 day and 
chemically fix as described below. The cells remaining attached to the dish are collected and 
used to evaluate isotope incorporation. 
Evaluation of Label Incorporation 
In order for analysis with the NanoSIMS to be successful, a sufficient amount of isotope 
label must be incorporated into the plasma membrane to ensure the lipid-specific secondary ions 
can be detected by NanoSIMS with satisfactory signal to noise. In addition, because only the 
isotope-labeled lipids will be visible in the NanoSIMS image, a high fraction of the lipid species 
of interest within the cell should contain the isotope label so that the isotope enrichment image 
was representative of that lipid’s distribution and density within the plasma membrane. The cells 
that remained attached to the dish after removing the silicon chips are used to assess the isotope 
incorporation into the lipid species of interest. Their lipids are extracted using a protocol that was 
adapted from the method of Bligh and Dyer,
17
 as described in the Materials and Methods section. 
Extractions are typically performed on approximately 2 × 10
6
 cells/pellet. 
LC-MS was used to determine the fraction of the cellular sphingolipids that contain 
nitrogen-15. The following mass peaks are monitored: m/z 703.6 (unlabeled N-palmitoyl 
sphingomyelin), 704.6 (
15
N-palmitoyl sphingomyelin), 719.6 (
14
N-palmitoyl 
13
C16-
sphingomyelin), 720.6 (
15
N-palmitoyl 
13
C16-sphingomyelin), and 735.7 (
14
N-palmitoyl 
13
C32-
sphingomyelin). For the cell lines used, no significant signal was detected for other sphingolipid 
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species. However, different cell lines may metabolize the lipid precursors into other sphingolipid 
classes, so the presence of ion peaks corresponding to other sphingolipid species should also be 
evaluated and included (if present) when determining the incorporation values. The contribution 
of N-palmitoyl sphingomyelin isotopologues other than 
15
N-palmitoyl sphingomyelin from peak 
m/z 704.6 was removed by subtracting 43.3% of the intensity of the N-palmitoyl sphingomyelin 
peak (m/z 703.6) from that of peak m/z 704.6. The contribution of sphingomyelin isotopologues 
other than 
15
N-palmitoyl 
13
C16 sphingomyelin to peak m/z 720.6 was removed by subtracting 
25.8% of the intensity of the 
14
N-palmitoyl 
13
C16 sphingomyelin peak at m/z 719.6 from that of 
peak m/z 720.6. The fraction of N-palmitoyl sphingomyelin that contained a nitrogen-15 isotope 
was calculated as the ratio of the sum of 
15
N-palmitoyl sphingomyelin and 
15
N-palmitoyl 
13
C16-
sphingomyelin peak intensities to the sum of the peak intensities from all N-palmitoyl 
sphingomyelin isotopologues. The fraction of N-palmitoyl sphingomyelin that biosynthesized 
from uniformly labeled 
13
C-palmitic acid was calculated as the ratio of the sum of 
14
N-palmitoyl 
13
C16-sphingomyelin, 
15
N-palmitoyl 
13
C16-sphingomyelin, and 
14
N-palmitoyl 
13
C32-
sphingomyelin, over the sum of the peaks produced by all N-palmitoyl sphingomyelin 
isotopologues. 
The fraction of the fatty acids within the cellular lipids that are uniformly labeled with 
carbon-13 was measured with GC-MS. For this purpose, the lipid extracts from the cells are 
hydrolyzed with base to release the fatty acids from the lipid backbone. Then the fatty acids are 
neutralized with acid and converted to methylesters by treatment with trimethylsilyldizomethane.   
GC-MS was performed on the resulting solution of fatty acid methyl esters (FAMEs). In positive 
electron impact mode (EI), the signal intensities corresponding to the FAMEs of 
13
C16-palmitic 
acid (m/z 286), 
12
C16-palmitic acid (m/z 270), 
13
C16-palmitoleic acid (m/z 284), 
12
C16- palmitoleic 
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acid (m/z 268), 
13
C18-stearic acid (m/z 316), 
12
C18-stearic acid (m/z 298), 
13
C18-oleic acid (m/z 
314), 
12
C18-oleic acid (m/z 296), 
13
C18-linoleic acid (m/z 312), and 
12
C18-linoleic acid (m/z 294) 
are collected. These intensities can then be correlated to determine a representative incorporation 
value. 
Cell Preservation with Chemical Fixation 
Imaging with the NanoSIMS was performed under ultrahigh vacuum conditions, so the 
cells must be dehydrated without perturbing the lateral distributions of lipids and proteins within 
the cell membrane. This was accomplished by chemically preserving the cells. The method 
described here was derived from protocols used to chemically fix cells in order to prepare them 
for analysis with scanning electron microscopy. This chemical fixation procedure produces a 
membrane whose morphology is retained during the inevitable drying process needed for 
introduction into the vacuum of the SIMS analysis chamber.
26
 Different chemical preservation 
protocols can be used as long as they involve a heavy fixation that can withstand ultrahigh 
vacuum conditions. In our method, chips with adherent cells are removed from cell culture and 
rinsed three times with HPB for 3 min each. Care was taken so as not to disturb the attached 
cells. The chips are flooded with 4% glutaraldehyde and allowed to fix for 30 min. An easy way 
of fixing and rinsing without wasting large amounts of material is to place the chips in a 
parafilm-lined dish and to use pipettes for transferring the liquids. The parafilm will encourage 
the liquids to pool onto the chip, and the pipettes can be easily used for placing a drop of liquid 
onto the chips or suctioning off and disposing used material. The glutaraldehyde was removed, 
and the chips are rinsed twice with HPB for 5 min each, followed by rinsing once with water for 
5 min. They are then fixed and stained with freshly diluted, freshly filtered 1% osmium tetroxide 
for 15 min. The osmium tetroxide was removed, and the chips are rinsed three times for 5 min 
39 
 
each with water. Excess water was removed; the samples are allowed to air dry, and are then 
stored at room temperature. 
Pre-Characterization of Cells 
To ensure efficient use of time on the NanoSIMS instrument, assessment of cell 
preservation was performed using bright field microscopy and low voltage SEM prior to 
NanoSIMS analysis. An optical map that shows the locations of cells in relation to one another, 
the scratches on the chip, and the edges of the chip was first created with bright field 
microscopy. Then, low voltage SEM was used to identify the cells that are best-suited for 
NanoSIMS analysis. This map will facilitate locating desirable cells during NanoSIMS analysis. 
Cells that are ideal for NanoSIMS analysis should be well-preserved (i.e., free of cracks or 
debris), relatively flat, and located away from the edges of the chip. The specific cells that are 
imaged with SEM should be indicated on the optical bright field map of the chip, which will be 
used to relocate them in the NanoSIMS. So, first, the entire surface of the chip was mapped with 
bright field imaging performed at 10-times or 20-times magnification. Starting at one corner of 
the chip, a series of overlapping images was acquired of the entire chip, and then these images 
were stitched together to create the optical map of the sample.  
Samples can be metal coated to ∼5 nm thickness. Sputter coating should be optimized for 
the individual sample and imaging conditions. A thicker coating should be employed if sample 
charging occurs. Gold, gold-palladium, iridium and other metals may be used, but carbon coating 
should not be used. SEM imaging was performed using low voltage to avoid sample charging 
and to prevent damage. SEM imaging at higher than 5 kV damages the sample. This damage is 
visible as cracks on the cells. Making small rasters on the sample, such as for higher 
magnification, can also cause damage in the form of the decomposition of molecules at the 
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surface of the cell. Images of individual cells are acquired at a low magnification (500–1,100×), 
and which cells are imaged with SEM was indicated on the optical map of the chip. 
SIMS Imaging 
The specifics of this section are based on a NanoSIMS 50. Other SIMS instruments can 
be used for this work, though with some loss in spatial resolution, sensitivity, specificity and/or 
analysis speed. 
NanoSIMS Settings 
The analysis conditions are set according to the species to be detected and the spatial 
resolution needed. Here, the parameters are set based on detecting 
12
C
1
H
−
, 
13
C
1
H
−
, 
14
N
12
C
−
, and 
15
N
12
C
−
 with 50–100 nm lateral spatial resolution. Carbon isotopes can also be detected using C–, 
C2
–
, and 
14
NC
–
. Other species can be detected on additional detectors. The target mass resolving 
power (MRP  ≡  M/ΔM) is 7,000 to resolve 13C2
−
 from 
14
N
12
C
−
 (ΔM  =  0.0037 amu) and 11B16O− 
from 
15
N
12
C
−
 (ΔM  =  0.0041 amu). Because of the way the NanoSIMS software calculates MRP, 
∼11,000 MRP must be obtained based on the NanoSIMS high mass resolution scan to achieve 
the functional mass resolving power of 7,000. Lower mass resolving power can be used if the 
13
C 
enrichment is low or natural abundance and BO
−
 counts are negligible. The cesium microbeam 
ion source was placed at 8,000 V and was mechanically aligned in the primary column based on 
maximizing the current at the primary Faraday cup (FCp). The filament current on the 
microbeam ion source reservoir was adjusted to achieve ∼30 nA Cs+. The sample was placed at 
−8,000 V. The L1 lens in the primary column was placed at approximately 6,500 V for high 
resolution (<100 nm), or left at zero for moderate resolution (∼150 nm). One should select a 150 
μm or smaller diameter aperture from the D1 aperture strip (primary beam limiting aperture) for 
the highest resolution (50 nm), 200 μm for high resolution (∼75 μm), or 300 μm for moderate 
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resolution. The resulting beam current at the sample, as measured at the object Faraday cup 
(FCo), should be ∼0.25 pA Cs+ for the highest resolution or ∼2 pA for moderate resolution. We 
then either adjust the reservoir current or perform more advanced alignment procedures to 
achieve the target beam current.  
The secondary ion beam must be aligned in the column in the total ion count detector 
with the secondary ion beam centering deflectors. This alignment is typically only performed 
with changes in instrument hardware. Next the desired masses are aligned in the individual 
detectors in the multicollection chamber. Both vertical and horizontal coincidence must be 
confirmed. To enable 11,000 MRP in NanoSIMS units (a functional 7,000 MRP), the 10  μm  × 
 100 μm entrance slit was aligned on the secondary ion beam by maximizing the current at the 
multicollector detectors; the 150  × 150 μm2 aperture slit was then aligned on the secondary ion 
beam in the same way. The secondary ion beam was next tuned using standard Cameca 
procedures to achieve ∼11,000 MRP. The primary beam focusing was performed in parallel with 
secondary ion beam focusing. The primary beam diameter on the sample, which determines 
image resolution, was checked at this point (as described below) to ensure the imaging target was 
achieved. The SIMS analysis location was aligned with the CCD optical imaging reticule using a 
reference sample. This alignment was necessary to allow centering on target cells without SIMS 
imaging. 
Sample Loading and Analysis Locations 
Sample chips should be loaded into a front-justified sample holder. The sample well in 
the holder can be 7.2 mm diameter, 5 × 5 mm squares, or a ∼6 mm diameter aperture in a larger 
hole. The samples should be held in place from behind by non-magnetic springs. We then 
introduce the sample holder into the analysis vacuum chamber after pumping in the airlock. 
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Prospective analysis locations are located in the CCD image based on the light microscopy and 
SEM imaging, and the coordinates are saved in the point table. Also we save the location of 
nearby cells that can be used for tuning. All sample chips on the holder can be mapped before 
moving to SIMS analysis position to save time. 
Cell Analysis 
The primary challenge of the sample analysis was to position the sample and align the 
secondary beam so that the tuning accomplished above was achieved with the target cells. 
Control samples should be analyzed in the same session to ensure analysis quality. First, we 
would move to SIMS analysis position and choose a starting area, go to the preselected tuning 
cell, and adjust sample height and secondary ion beam steering. It was necessary to check MRP 
and peak alignment, ensuring that interfering isobars are not collected (Fig. 2.1 and Table 2.1). 
Significant changes in MRP or peak alignment potentially indicate excessive sample topography. 
Adjustments in tuning can be made to improve MRP, but caution is necessary to assure analysis 
quality. Note that abundances are calculated relative to isotopologues and cannot be directly 
compared to other molecules. For example, the yield of CN
−
 is typically ∼10× that of C2
−
, 
although it is unlikely that CN
-
 was present at 10× higher levels than C2
-
. After tuning was 
complete, we would turn off the primary beam and move to the desired starting location on the 
target cell. Five to ten micrometers leeway was allowed for stage drift and misalignment of the 
CCD and SIMS imaging. The analysis conditions were set so that the primary beam cross section 
from pixel to pixel overlaps by at least 50%. The scan rate was set to enable multiple scans 
before eroding through the plasma membrane (e.g., 512 × 512 pixels, 15 × 15 μm2, 0.5–1 
ms/pixels, 3–5 scans; see below for calculation of sputter depth). Target species (e.g., 12C1H−, 
13
C
1
H
−
, 
14
N
12
C
−
 and 
15
N
12
C
−
) and secondary electrons are collected. 
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Data Analysis 
Determination of Analysis Depth 
Determination of the sputtering depth was straightforward, involving use of established 
formulas and procedures. To ensure that the vast majority of secondary ions are produced by the 
cell membrane and few secondary ions are collected from the underlying cytoplasm, the 
sputtering depth should be less than the sum of the thicknesses of the membrane (7.5 nm)
27
 and 
the metal coating (∼5 nm). If the sputtering depth exceeds the membrane thickness, it can be 
reduced by discarding some of the image planes. Because the sputtering depth increases with 
each subsequent image plane, the last image plane(s) to be acquired should be discarded until the 
sputtering depth is less than approximately 5 nm.  
The sputtering depth (Dsp) was calculated using the sputter rate (Rsp), primary ion beam 
current at the sample (FCo) in pA, raster area (Aras) in μm
2
, and the sputtering time (tsp) in 
seconds. The sputter rate determined on other biological samples, which ranges from 0.9 
nm·μm2/pA·s (unpublished results) to 2.5 nm·μm2/pA·s 11 may be employed. The primary ion 
beam’s current at the FCp and raster area were recorded during NanoSIMS analysis. The primary 
ion beam current at the sample (FCo) must be measured separately. The sputtering time (tsp) is 
calculated using the dwell time (tdw) for each pixel (pxl), the total pixels (pxltot) per image plane, 
and the total number of image planes (NP) according to Eq. 2.1. 
 Sputtering time = (
dwell
pixel
) (
total pixels
image plane
) (number of image planes) (2.1) 
For example, for a 512 × 512 pixel image consisting of four image planes that were each 
acquired with a dwell of 1 ms/pixel, the total sputtering time is 1048.576 s. We calculate the 
sputtering depth in nanometers using Eq. 2.2. 
 Sputtering depth = (
sputter rate ×primary ion beam current ×sputter time
raster area
) (2.2) 
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Determination of Lateral Spatial Resolution 
Lateral resolution was also determined using standard procedures. The primary challenge 
is to find a sufficiently small or sharp edged feature so that its width is negligible relative to the 
primary beam diameter. To determine the spot size, a single scan of a standard sample is used. 
To determine the practical resolution, multiple scans of a cell sample can be used, but with the 
caveat that the features may not be sufficiently small or sharp to accurately characterize the beam 
diameter. To do this, we first collect a secondary electron image of a standard sample (256  × 
 256 pixels, 5  ×  5 μm2, 0.5–1 ms/pixels) or use an image that has already been collected of a cell 
(see above). For multi-scan images, one will need to align the NanoSIMS image planes to correct 
for spatial drift in the beam or the sample. The presence of image drift would compromise the 
lateral resolution of the resulting image. Images of high count rate species, such as 
12
C
14
N– or 
secondary electrons, typically provide the best alignment for cells. Next, we calculate the 
effective diameter of the primary ion beam, to determine the lateral resolution of the NanoSIMS 
analysis. To do this, we make a line scan across a region in a secondary ion or secondary electron 
image where the sample composition changes abruptly. We determine the distance over which 
the secondary ion or electron signal intensity changes from 84% to 16% of the maximum 
intensity. This distance was the effective diameter of the analysis beam.
8
 
Creation of 
15
N- and 
13
C-Enrichment Images 
To accurately visualize the distribution of 
15
N-sphingolipids and 
13
C-lipids in the plasma 
membrane, the secondary ion signal must be normalized to remove ion intensity variations due to 
concentration-independent factors that affect ion yields and sputter rates.
28
 These factors include 
changes in ionization probabilities related to sample composition—which is referred to as 
“matrix effects”—and sample topography.29–31 Because these concentration-independent factors 
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influence the intensities of isotopologues, which are chemical species that differ in isotopic 
composition (i.e., 
15
N
12
C
−
, 
14
N
13
C
−
 and 
14
N
12
C
−
), to relatively the same extent, expressing the 
lipid-specific ion counts as a ratio to the corresponding major ion accurately represents the 
concentration distribution of the target molecules.
28
 To minimize random noise in the images, the 
ratio images are typically “smoothed” over a 3 by 3 pixel window, which means the value at a 
given pixel is the average ratio of the 3 by 3 pixel region that is centered around that pixel.  
Once again, image processing begins with aligning the image plane. For each image 
plane, we ratio the counts of each lipid-specific ion (e.g., 
15
N
12
C
−
or 
13
C
1
H
−
) detected at each 
pixel to the counts of the corresponding major element ion (
14
N
12
C
−
 or 
12
C
1
H
−
) detected at the 
same pixel. We then smooth the isotope ratio measured at each pixel using a 3 by 3 pixel 
window. For every pixel, we calculate the mean (μ) isotope ratio (15N12C−/14N12C− or 
13
C
1
H
−
/
12
C
1
H
−) of the individual image planes (μ  =  Σxi/N, where N was the number of total 
image planes). The isotope ratio (
15
N
12
C
−
/
14
N
12
C
14
N
−
 or 
13
C
1
H
−
/
12
C
1
H
−
) was then divided by 
their natural abundance (0.00367 or 0.011237, respectively) to produce an enrichment factor that 
was a quantitative relative measure of the amount of 
15
N-sphingolipids or 
13
C-lipids in the 
plasma membrane compared to an unlabeled (natural abundance) cell. Finally, a color scale was 
used to encode the value of the isotope enrichment measured at each pixel in the output image 
with a color (Fig. 2.2). 
Visual Interpretation of 
15
N- and 
13
C-Enrichment Images 
The 
13
C-enrichment and 
15
N-enrichment images (Fig. 2.2) reveal the distributions of 
13
C-
labeled lipids and 
15
N-sphingolipids in the plasma membrane. The 
13
C-lipid distribution was 
used to assess the quality of cell preservation. As shown in the 
13
C-enrichment image in Fig. 2.2, 
the continuity of the 
13
C-enrichment on the cell surface confirms that the cell membrane was 
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intact, and the 
13
C-lipids are not clustered within the membrane. This continuous distribution of 
13
C-lipids on the cell surface confirms that the preservation process did not create holes in the 
membrane, or induce artifactual lipid clustering. Therefore, the lateral variations in the 
15
N-
enrichment on the cell surface (Fig. 2.2), which indicate that the 
15
N-sphingolipids are 
heterogeneously distributed in the cell membrane, cannot be attributed to preparation-induced 
artifacts. Instead, the local elevations in the 
15
N-sphingolipid enrichment that are dispersed 
within a continuous matrix of lower 
15
N-sphingolipid abundance signify the presence of 
15
N-
sphingolipid domains within the plasma membrane.  
Conclusions 
Advances in secondary ion mass spectrometry (SIMS) now enable the distributions of 
isotopically labeled lipids within cellular or model membranes to be imaged with chemical 
specificity and high (≥50 nm) lateral resolution.  Methods to image the distributions of 
sphingolipids within the membranes of intact cells with a Cameca NanoSIMS were described in 
this chapter.  This includes the metabolic incorporation of distinct stable isotopes into the lipid 
species of interest, cell preservation, imaging conditions, and data analysis, which are all 
essential for lipid detection with a NanoSIMS. By using this approach to image large regions on 
the cell surface, the long-range organization of the sphingolipid microdomains in the plasma 
membrane may be visualized. The methods and principles described here can also be extended to 
studying other membrane lipids or cholesterol. Such work is described in the subsequent 
chapters. 
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Figures and Tables 
 
Figure 2.1  Mass spectra acquired with ∼11,000 MRP and 75 μm-width slits in front of the 
detectors. The analyzed cell was isotopically enriched in 
13
C and 
15
N. The ions of interest and 
some of the interfering isobars at m/z 13, m/z 14, m/z 26, and m/z 27 are indicated. The individual 
masses are not resolved in these scans, but by setting the deflection on each detector as indicated 
with the dashed lines, the contribution of the interfering isobars was less than 0.1% of the species 
of interest. Several species are too low in abundance to be visible in the mass spectra (see Table 
2.1 for the full list of interferences at m/z 26 and 27). 
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Table 2.1 Mass Interferences 
52 
 
Figure 2.2  NanoSIMS images acquired from a fibroblast cell. The secondary electrons were 
acquired in parallel with the 
12
C
1
H
−
, 
13
C
1
H
−
, 
14
N
12
C
−
 and 
15
N
12
C
−
 secondary ions. To image the 
entire cell at this lateral resolution, multiple overlapping images are required. Low ion counts at 
edges of images (below and to the left of the dashed lines) are characteristic of previously 
analyzed locations. The 
13
C-enrichment ((
13
C
1
H
−
/
12
C
1
H
−
)/0.011237) and 
15
N-enrichment 
((
15
N
12
C
−
/
14
N
12
C
−
)/0.00367) images reveal the distributions of 
13
C-labeled lipids and 
15
N-
sphingolipids in the plasma membrane. The secondary ion and enrichment images were 
smoothed over 3 by 3 pixels. 
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CHAPTER 3. 
DIRECT CHEMICAL EVIDENCE OF SPHINGOLIPID DOMAINS ALLOWS FOR 
FURTHER CHARACTERIZATION 
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Introduction 
Spatial organization of the lipids and proteins in the plasma membranes of eukaryotic 
cells is critical to coordinating lipid signaling and numerous other processes that occur at the cell 
surface.
3
 Thus, the hypothesis that lipids self-organize in compositionally and functionally 
distinct plasma membrane domains has been investigated for decades.
4
 Microdomains with a 
variety of lipid compositions and dependencies on lipid and protein interactions may exist in the 
plasma membrane,
5–7
 but the most compelling lipid microdomain is the lipid raft because such 
domains self-assemble in synthetic membranes.
8,9
 Lipid rafts are defined as dynamic and small 
(10- to 200-nm) plasma membrane domains that are enriched with cholesterol and 
sphingolipids.
8,9
  Despite intense research, the distributions of most lipid species, including 
cholesterol and sphingolipids, in cellular membranes are still difficult to determine.
9
 The ability 
to directly visualize specific lipid species without the use of potentially perturbing tags would 
help to address outstanding questions regarding distinct lipid domains in the plasma membrane.
9–
11
  
Here we use a high-resolution chemical imaging approach to address the question: How 
are sphingolipids distributed in the plasma membranes of intact cells? We focused on 
sphingolipids because (i) they are postulated to be segregated within compositionally distinct 
lipid domains, such as lipid rafts,
12–14
 and (ii) sphingolipid metabolites are signaling molecules 
that regulate cell survival and proliferation.
15
 We studied a transfected mouse fibroblast cell line 
that stably expresses influenza hemagglutinin (Clone 15 cell line) because the hemagglutinin 
clusters in their plasma membranes are thought to be associated with sphingolipid and 
cholesterol domains.
12–14
 Thus, we hoped to increase the probability of detecting sphingolipid-
enriched plasma membrane domains by using the Clone 15 cell line.  
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To visualize the sphingolipids within the plasma membrane, we isotopically labeled them 
and then mapped their distributions in the plasma membrane, using a secondary ion mass 
spectrometry (SIMS) instrument (Cameca NanoSIMS 50) with 50-nm lateral resolution and an 
analysis depth of <5 nm at the cell surface;
16–18
 this analysis depth is less than the thickness of 
the plasma membrane. Previous reports establish that NanoSIMS imaging does not alter 
biomolecule distribution within subcellular compartments or lipid membranes.
16,19–21
 Thus, this 
approach enabled us to quantitatively determine the sphingolipid organization. Sphingolipids 
were segregated in ∼200-nm diameter microdomains that nonrandomly clustered into 
sphingolipid-rich plasma membrane patches with micrometer-scale dimensions. Sphingolipid 
organization was not altered by chemical fixation or cell preservation temperatures, but 
treatments of the plasma membranes, such as with latrunculin-A, show a measurable effect on 
sphingolipid distribution in the plasma membrane. 
Methods and Materials 
Materials 
Uniformly 
13
C-labeled (98 atom%) fatty acids were from CambridgeIsotope Laboratories. 
Fatty acid-free bovine serum albumin (FAFBSA) and 
13
C18-stearic acid (99 atom% 
13
C) were 
from Sigma. Lipid-reduced fetal bovine serum (LR-FBS) and calf serum were from HyClone 
Laboratories. Poly-L-lysine and fixation reagents were from Electron Microscopy Sciences. 
Standard cell growth medium consisted of high-glucose Dulbecco’s modification of Eagle’s 
medium (DMEM) supplemented with 10% (vol/vol) calf serum, 10
4
 units/mL penicillin G, and 
10 mg/mL streptomycin. BODIPY-sphingosine and 
15
N-sphingolipid precursors (
15
N-
sphingosine and 
15
N-sphinganine, 1:1 molar ratio) were synthesized as reported in refs.
22–24
 
Latrunculin A for cytoskeleton disruption was from Cayman Chemical. The Clone 15 cell line 
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was obtained by standard techniques for selecting stably transfected cells after transient 
expression in a NIH 3T3 mouse fibroblast line with a DNA plasmid for the hemagglutinin from 
the 1957 pandemic Japan strain of influenza. 
Metabolic Labeling of Cells 
Cells were metabolically labeled as was previously described in Chapter 2. 
Depolymerization of Actin Cytoskeleton 
After metabolic labeling of the cells is complete, substrates with their adherent cells are 
removed from the cell culture and placed into culture dishes containing Media B and 0.83 µM of 
latrunculin A. After 30 min of exposure, substrates are removed, and the latrunculin A-treated 
cells are chemically preserved as described below. Control cells were generated by culturing 
cells in the presence of dimethyl sulfoxide (the solvent for latrunculin A) instead of latrunculin 
A. The effects of latrunculin A were visually confirmed through the use of a light microscopy as 
well as secondary electron microscopy (SEM). 
Evaluation of Label Incorporation 
The evaluation of the isotopic label content in cell samples was performed as previously 
described in Chapter 2. This information includes specifics on lipid extraction from cells, liquid 
chromatography mass spectrometry settings, and gas chromatography mass spectrometry settings 
as well as other pertinent information. 
Cell Preservation with Chemical Fixation 
Imaging with the NanoSIMS is performed under ultrahigh vacuum conditions, so the 
cells must be dehydrated without perturbing the lateral distributions of lipids and proteins within 
the cell membrane. This was accomplished by chemically preserving the cells. The method 
described here is derived from protocols used to chemically fix cells in order to prepare them for 
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analysis with SEM. This chemical fixation procedure produces a membrane whose morphology 
is retained during the inevitable drying process needed for introduction into the vacuum of the 
SIMS analysis chamber.
25
 In this method, chips with adherent cells are removed from cell culture 
and rinsed three times with Hendry’s Phosphate Buffer (HPB) for 3 min each. Care was taken so 
as not to disturb the attached cells. The chips were flooded with 4% glutaraldehyde and allowed 
to fix for 30 min. The glutaraldehyde was then removed, and the chips were rinsed twice with 
HPB for 5 min each, followed by rinsing once with water for 5 min. They were then fixed and 
stained with freshly diluted, freshly filtered 1% osmium tetroxide for 15 min. The osmium 
tetroxide was removed, and the chips were rinsed three times for 5 min each with water. Excess 
water was removed; the samples were allowed to air dry, and were then stored at room 
temperature. This preservation protocol was performed either at room temperature or at 
biological temperature (37°C). In order to achieve biological conditions, fixation reagents 
(buffers, glutaraldehyde, osmium tetroxide, water) were pre-warmed to 37°C. During the fixation 
process, the cells were kept in an incubator to ensure the appropriate temperature. After the final 
rinses with water, the samples were allowed to air dry and then stored at room temperature. 
Low-voltage SEM 
SEM imaging was performed using a Hitachi S-4800 SEM.  Low voltage was used to 
avoid sample charging and to prevent damage. SEM imaging at higher than 5 kV damages the 
sample. This damage is visible as cracks on the cells. Making small rasters on the sample, such 
as for higher magnification, can also cause damage in the form of the decomposition of 
molecules at the surface of the cell. Images of individual cells were acquired at a low 
magnification (500–1,100×), and which cells were imaged with SEM was indicated on the 
optical map of the chip. 
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Formation of Thin Iridium Layer on Cell Samples. 
 To prevent charging during NanoSIMS analysis, a Cressington 208HR High-Resolution 
Sputter Coater equipped with a low-voltage planar magnetron sputter head, a rotary-planetary-
tilting stage, and a Cressington MTM-20 High-Resolution Thickness Controller was used to 
produce the 3-nm-thick iridium coatings on the cells. The sample stage was rotated and tilted 
approximately ±30° during the entire metal sputtering process to minimize variations in the 
iridium coating thickness that might be caused by sample topography. To reduce the amount of 
impurities present in the resulting iridium metal coating on the samples, high-purity (99.95%) 
iridium was used as the source, and the source was presputtered to remove surface contamination 
before opening the shutter.  
SIMS Analysis 
SIMS was performed on a Cameca NanoSIMS 50 at Lawrence Livermore National 
Laboratory with a 0.129-pA, 15-keV 
133
Cs
+
 primary ion beam focused onto a 69-nm spot. Four 
replicate scans of 512 × 512 pixels with a dwell time of 1 ms/pixel were acquired for each 15 × 
15-µm analysis region, resulting in a pixel size (29 × 29 nm) smaller than the beam diameter. 
The 
12
C
1
H
−
,
13
C
1
H
−
, 
12
C
14
N
−
, and 
12
C
15
N
−
 secondary ions, and secondary electrons, were 
simultaneously collected. A mass resolving power of ∼6,700 was used to separate isobaric 
interferences from the isotopes of interest, e.g., 
12
C
15
N
−
 from 
13
C
14
N
−
 at mass 27. The primary 
ion dose was 4.5 × 10
14
 ions/cm
2
.  
Data Analysis 
NanoSIMS data were processed with a custom software package (L’image; L. R. Nittler, 
Carnegie Institution of Washington, Washington, DC) run with PV-Wave (Visual Numerics; 
presently known as Rogue Wave). Quantitative
15
N- and 
13
C-enrichment images showing the 
15
N-
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sphingolipid and 
13
C-lipid distributions, respectively, were constructed using a 3 × 3-pixel 
moving average smoothing algorithm. Isotope enrichment is the 
12
C
15
N
−
/
12
C
14
N
−
 or 
13
C
1
H
−
/
12
C
1
H
−
 ratio divided by standard natural abundance ratios (0.00367 and 0.011237, 
respectively). The MATLAB statistics toolbox was used to determine the statistically significant 
thresholds for 
15
N-enrichment and to perform Kolmogorov-Smirnov tests for statistically 
significant differences in the 
15
N-sphingolipid domains.  
Analysis of Sphingolipid Domain Organization 
The clustering of the domains on the cell body was assessed using the SpatStat spatial 
statistics package (version 1.22-1) run in the R program (version 2.12.2).
26,27
 The x–y 
coordinates for the cell body were recorded by loading the montage of secondary electron images 
of the cell into GraphClick 3.0 and tracing the edges of the cell body but omitting the 
lamellipodia. The coordinates for the cell body were expressed in pixel units and were used to 
define the observation window in SpatStat. The x–y coordinates of the domain centers with 
respect to the whole cell were calculated from the coordinates of the pixels where the domain 
centers were located within each 
15
N-enrichment image (exported from L’image) and the 
coordinates of each 
15
N-enrichment image in the montage of the whole cell. These coordinates 
were used to create a point pattern that represented the observed domains within the observation 
window that corresponded to the cell body.  
Ripley’s K-test was performed on the point pattern corresponding to the domain centers, 
using translation edge correction to calculate the number of domains within a radius, r, of any 
domain on the cell surface.
28,29
 Analysis was restricted to distances less than one-quarter of the 
smallest length of the observation window. Data were normalized to the 99% confidence 
interval, calculated according to  
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 CI99 = 1.68√A/N    (3.1) 
A is the area of the observation window and N is the total number of domains within the 
window.  
For comparison with the experimental domains observed on the cell surface, we 
simulated a population of spatially random domains within the observation window that 
represented the cell body. The number and effective diameters of the domains in the simulated 
population were identical to those that were experimentally observed on the cell body. We first 
determined the frequency distribution of effective domain diameters experimentally observed on 
the cell body, using a bin size of 1 pixel. We tabulated the number of domains with a specified 
effective diameter that were experimentally observed on the cell body. An algorithm was used to 
randomly add domains (“points”) with the specified effective diameter (encoded as a “mark”) 
one-by-one to the observation window that represented the cell body. New domains were 
generated independent of the preceding domains, and those that lay outside of the observation 
window were rejected. To prevent the domains from overlapping, the simulated domains were 
also rejected if the distance between the center of the simulated domain and the center of the 
closest domain was less than the sum of the radii of the two domains. Once the number of 
domains with a given diameter in the observation window equaled that experimentally observed 
on the cell body, the process was repeated for the next effective domain diameter. These steps 
were repeated until the correct number of domains had been simulated for every observed 
effective diameter.  
The nearest neighbor distance, which is the distance from the center of each domain to 
the center of its nearest neighbor, was computed for each of the (i) experimentally observed 
domains on the cell body and (ii) simulated, spatially random domains. For each population (e.g., 
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experimental and simulated), the frequency distribution of nearest neighbor domain distances 
was tabulated using a bin size of 50 nm and normalized to the total number of domains in the 
population to produce the fraction of the total. The difference between the frequencies of 
observed and simulated nearest neighbor distances was calculated by subtracting the fraction of 
the simulated domain population with nearest neighbor distances within each 50-nm increment 
from the fraction of experimentally observed domains with nearest neighbor distances in the 
same range. The differences between the frequencies of observed and simulated nearest neighbor 
distances are plotted in Fig. 3.6F.  
The pairwise domain distances, which are the distances between the center of each 
domain and the center of every other domain on the cell body, were computed for (i) every 
domain that was experimentally observed and (ii) every domain within the simulated population. 
The frequency distributions of pairwise domain distances for the experimental and simulated 
domains on each cell were tabulated using a bin size of 0.5 μm and normalized to the total 
number of domains in the population. The difference between the frequencies of observed and 
simulated pairwise domain distances was calculated for each 0.5-μm increment and is plotted in 
Fig. 3.6G. 
SIMS Analysis of 
13
C-Lipid Dstribution Throughout the Cell. 
A series of 36 NanoSIMS 
13
C-enrichment images were sequentially acquired at the same 
sample position on a representative Clone 15 cell that was metabolically labeled and prepared as 
previously described. To permit analysis of the cytoplasm, the NanoSIMS operating conditions 
were adjusted so that the sampling depth was approximately four times greater than that used to 
acquire the rest of the NanoSIMS images presented herein. All other analysis conditions 
remained constant. Approximately 1.3 nm of material was sputtered from the sample surface 
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each time an image was acquired. The resulting data provided a depth profile of the cell at that 
location. 
Results 
NanoSIMS Images Show Sphingolipid-Enriched Domains in the Plasma Membrane 
Secondary electron images of the Clone 15 fibroblast cells were collected simultaneously 
to the secondary ions to allow the isotopic data to be related to cell location and morphology 
(Fig. 3.1). The high levels of 
15
N-isotope incorporation into the cellular sphingomyelin allowed 
the location and density of sphingolipids in the membrane to be mapped with a high signal-to-
noise ratio. Local elevations in 
15
N-enrichment were dispersed within a matrix of lower 
15
N-
enrichment on the surfaces of the Clone 15 cells (Fig. 3.2). Control experiments excluded the 
possibilities that these local elevations in 
15
N-enrichment were artifacts induced by cell 
topography, the iridium coating, or isotope-labeled material adsorbed to the cell. Consequently, 
these local elevations in 
15
N-enrichment are plasma membrane domains enriched with 
15
N-
sphingolipids. These sphingolipid microdomains were detected on every one of over 25 other 
cells studied. Based upon the analysis of 59,301 3 × 3-pixel subregions on the Clone 15 cell 
shown in Fig. 3.2, a 
15
N-enrichment factor ≥12 is at least 2 SD above the mean 15N-enrichment 
factor for the domain-free regions (mean 
15
N-enrichment factor for domain-free regions = 7.8, 1 
SD = 2.1) and therefore represents a statistically significant elevation in the plasma membrane’s 
local 
15
N-sphingolipid enrichment. The 
15
N-sphingolipid–enriched domains on this cell (Fig. 3.2) 
and others (Table 3.1) were more abundant on the main body of the cell than on its extensions. 
Debris on the substrate near the cell was also enriched with 
15
N-sphingolipids, consistent with 
reports that fibroblasts deposit lipids along with other cellular material when migrating.
30
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Because the 
15
N-sphingolipid assemblages were larger than expected, we carefully 
inspected the 
13
C-lipid distribution shown in the 
13
C-enrichment images for signs of membrane 
defects or spatially dependent variations in detection sensitivity. The specificity of the elevated 
13
C-enrichment to 
13
C-lipids was confirmed by its localization at the surfaces of identically 
labeled cells and at distinct regions in their cytoplasm that likely correspond to organelle 
membranes (Fig. 3.4). Therefore, the continuously elevated 
13
C-enrichments detected on the 
Clone 15 cells in Fig. 3.3 and Fig. 3.4 confirm their plasma membranes were intact, and the 
regions of lower 
15
N-sphingolipid abundance are not artifacts of membrane damage. The absence 
of statistically significant variations in the 
13
C-enrichment on the surfaces of the cells as a 
function of distance from the nucleus indicates the analysis sensitivity was laterally uniform. 
Finally, we tested whether the local elevations in 
15
N-sphingolipid abundance reflected an excess 
of all cellular lipids, which could be caused by intracellular membranes adjacent to the plasma 
membrane or fixation-induced lipid aggregates. An excess of cellular lipids at the sites of 
15
N-
sphingolipid enrichment produces a concomitant statistically significant elevation in the 
13
C-
enrichment (not shown). For the Clone 15 cell shown in Fig. 3.2, the 
13
C-enrichment factors in 
the domains are not statistically higher than in the nondomain regions (Kolmogrov–Smirnov test, 
h = 0, P = 0.60). This confirms the local 
15
N-sphingolipid enrichment in the plasma membrane 
was not caused by intracellular membranes or artifactual lipid clustering.  
Sphingolipid Organization Is Not Altered by Chemical Fixation. 
We investigated the possibility that our fixation procedure altered the sphingolipid 
distribution in the plasma membrane. Control experiments were performed to test whether room 
temperature fixation or any other unavoidable exposure to subphysiological temperatures before 
fixation caused nanoscale sphingolipid domains to coalesce into the assemblages we observed 
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with SIMS. Low temperatures can induce phase separation in model membranes and 
sphingolipid clustering in the plasma membranes of unfixed cells.
31,32
 This redistribution of 
lipids does not occur when the cells are preserved with aldehyde fixatives similar to those we 
used before their exposure to subphysiological temperatures.
31
 Thus, lipid rearrangement could 
have occurred in our experiments only when the cells were removed from their incubator and 
subsequently exposed to room temperature (RT) glutaraldehyde solution. We compared Clone 15 
cells that were chemically fixed with RT and 37 °C glutaraldehyde solutions. The 
15
N-
sphingolipid microdomains on the cells fixed at 37 °C (Fig. 3.5) were similar in appearance to 
those in the membranes of cells fixed at RT. Thus, RT fixation did not induce the formation of 
15
N-sphingolipid domains in the plasma membrane.  
To assess whether RT fixation increased the size or abundance of the 
15
N-sphingolipid 
domains on the cell surface, we compared the mean sphingolipid domain size and surface 
coverage on cells fixed with RT and 37 °C glutaraldehyde solutions. By visual inspection, both 
sets of cells exhibited 
15
N-sphingolipid–enriched plasma membrane domains with circular and 
oblong morphologies, where the domain’s longest axis ranged from ∼200 nm to 2 μm. By using 
a particle definition algorithm to quantitatively define the sphingolipid domains, we determined 
each Clone 15 cell that was fixed at 37 °C had >1,400 sphingolipid-enriched domains that 
covered 8–13% of the cell surface (Table 3.1). Similar sphingolipid domain surface coverage 
was measured on each Clone 15 cell fixed at RT (9–15%). Because the majority of the 
sphingolipid domains were oblong (Fig. 3.6 A–C), we quantified their area and equivalent 
diameter, which is the diameter of a circular region with the same area. The sphingolipid 
domains on the cells fixed with RT glutaraldehyde solution had mean areas between 0.029 and 
0.038 μm2 and mean equivalent diameters between 180 and 205 nm (Table 3.1). Similar 
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sphingolipid domain areas and diameters were measured on the cells fixed at 37 °C (Fig. 3.6 and 
Table 3.1). Thus, the glutaraldehyde fixation temperature and kinetics did not affect the surface 
coverage or size of the sphingolipid domains.  
Sphingolipid Organization is Dependent on the Cytoskeleton 
We probed the hypothesis that the cytoskeleton and its associated proteins control 
membrane lipid organization. We disrupted the cytoskeleton in Clone 15 cells by exposing them 
to the actin-depolymerizing drug, latrunculin A,
33
 and assessed the effects on the sphingolipid 
domains in the plasma membrane. The extensive rounding of the cell shown in the NanoSIMS 
secondary electron images (Fig. 3.7A) confirms the latrunculin A treatment disrupted the 
cytoskeleton in this Clone 15 cell. In contrast to the cells with intact cytoskeletons, the 
15
N-
sphingolipids on the body of the latrunculin A–treated cell were not enriched within micrometer-
scale domains and instead appeared to be randomly distributed (Fig. 3.7B). Only a few 
15
N-
sphingolipid aggregates that approach the dimensions of the large 
15
N-sphingolipid domains 
observed on the untreated Clone 15 cells are visible on the mesh of thin extensions that stem 
from the rounded cell body. The 
13
C-lipids were fairly evenly distributed on the cell surface, 
although lower abundances of 
13
C-lipids were detected at the lower left and right sides of the 
rounded cell body. The presence of 
13
C-lipids on the substrate adjacent to the cell body suggests 
that membrane fragments detached from the cell when rounding occurred (Fig. 3.7C). The 
reproducibility of these results was tested across cell lines (Fig. 3.8) On the basis of these results, 
we conclude that an intact cytoskeleton is obligatory for sphingolipid-enriched plasma 
membrane domains. This type of finding illustrates the usefulness of SIMS imaging as a means 
for elucidating biological questions. 
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Discussion and Conclusion 
We can now refute the hypotheses that sphingolipid-enriched domains in the plasma 
membrane are nanoscopic or nonexistent,
9–11
 as we have directly imaged domains of 
sphingolipids on the dorsal surfaces of intact cells by combining metabolic labeling with high-
resolution SIMS. Sphingolipids are enriched within ∼200-nm diameter membrane microdomains 
that cluster into larger domains primarily within 5- to 10-μm diameter patches on the cell body. 
These sphingolipid domains are highly dependent on the cytoskeleton. These domains cannot be 
attributed to label-induced perturbations in molecular interactions or sphingolipid trafficking 
because the 
15
N-sphingolipids we imaged were biosynthesized by the cell and they have the same 
chemical structure as native sphingolipids. Although we acquired chemical images of fixed cells, 
our data indicate that they represent snapshots of the sphingolipid organizations that were present 
in living Clone 15 cells. This conclusion is supported by (i) exclusion of artifactual elevations in 
the local 
15
N-sphingolipid abundance caused by vesicles adjacent to the membrane; (ii) exclusion 
of temperature-induced sphingolipid reorganization during preservation; and (iii) analytical 
controls. These experiments lay to rest the debate over the existence of compositionally distinct 
lipid domains in the plasma membrane that has been in the literature for decades and lead us to 
reject models of membrane organization that feature spatially homogeneous lipid compositions. 
We undertook this study with Clone 15 cells because we expected these cells contained 
sphingolipid domains that could be detected with NanoSIMS. This expectation was based on the 
hypothesis that the micrometer-scale patches of darkly staining membrane lipids associated with 
the influenza hemagglutinin clusters were cholesterol- and sphingolipid-enriched rafts that 
coalesced due to favorable interactions with hemagglutinin.
12,14
 We successfully detected 
sphingolipid domains in the plasma membranes of the Clone 15 cells. Moreover, the properties 
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of the sphingolipid domains we observed, which include their micrometer-scale dimensions and 
their distribution on the cell, are inconsistent with those of lipid rafts. Nonrandom sphingolipid 
clustering was drastically affected by cytoskeleton disruption. On the basis of reports of a size 
difference between GM1 and GM3 domains and their segregation from one another,
6,34,35
 we 
expect that the plasma membrane contains multiple types of microdomains that differ in 
sphingolipid subspecies composition and size. Accordingly, the micrometer-scale sphingolipid 
patches we observed in the Clone 15 cells likely consist of microdomains that are each enriched 
with a different sphingolipid subspecies. Further studies involving the simultaneous imaging of 
numerous sphingolipid subspecies are required to test these hypotheses. 
If the plasma membrane contains sphingolipid domains with up to micrometer-scale 
dimensions, why are sphingolipid-enriched plasma membrane domains widely expected to have 
diameters below 200 nm? The expectation of nanometer-scale sphingolipid domains is primarily 
based on the assumption that all sphingolipid domains are lipid rafts, which are defined as 
nanoscale domains that are enriched with sphingolipids, cholesterol, and 
glycosylphosphatidylinositol(GPI)-anchored proteins.
8,9
 Consequently, consideration must be 
given to how raft size has been deduced. Because cohesive interactions between cholesterol, 
sphingolipids, and GPI-anchored proteins are postulated to induce lipid raft formation, domain 
sizes <200 nm have been inferred from the cholesterol-dependent clustering and diffusion of 
GPI-anchored proteins and sphingolipids.
34,36–38
 However, numerous studies have demonstrated 
that the clustering and hindered diffusion of GPI-anchored proteins and lipids are regulated by 
cortical actin organization.
6,39–42
 The indirect relationship between cholesterol-dependent 
biophysical properties and the local lipid composition in the plasma membrane renders inferring 
sphingolipid domain size from biophysical behavior less reliable than directly imaging the 
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sphingolipid components. Visualization of sphingolipid distribution via use of fluorescently 
labeled sphingolipid analogs or sphingolipid-specific affinity labels has revealed plasma 
membrane domains that differ in sphingolipid subspecies composition and size.
6,34,35,43–45
 As 
mentioned above, GM1 and GM3 are located in separate domains that have diameters <300 
nm,
6,34,35
 whereas sphingomyelin is enriched in plasma membrane domains with micrometer-
scale dimensions.
43–45
 Because micrometer-scale sphingomyelin domains are inconsistent with 
the expected size range for lipid rafts, these findings have been largely dismissed as artifacts 
caused by fluorophore-induced clustering or antibody cross-linking. Our chemical imaging 
method that employs nonperturbing stable isotope labels confirms that sphingolipid domains 
have micrometer-scale dimensions. Altogether, these findings indicate that the majority of 
sphingolipid domains in the plasma membrane are not lipid rafts, so the dimensions of 
sphingolipid domains cannot be inferred from properties ascribed to lipid rafts. 
High-resolution SIMS detection of metabolically labeled sphingolipids provides direct 
evidence for micrometer-scale sphingolipid-enriched patches composed of numerous 
microdomains in the plasma membranes of fibroblast cells. These domains are organized in 
multiple hierarchical levels. The properties of the sphingolipid domains we observed, size and 
location, indicate that they are not lipid rafts. Instead, our data support a model in which protein 
scaffolds consisting of the cytoskeleton and its associated proteins compartmentalize the plasma 
membrane.
5,7,46
 By adding this unique dimension of analysis—chemically specific compositional 
imaging at the scale of tens of nanometers—unique insight into the causes and functional 
consequences of plasma membrane organization is obtained. 
Overall, the dependence of the sphingolipid domains on an intact cytoskeleton supports a 
plasma membrane model in which lipid and protein organization is actively established by 
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remodeling of the cortical actin.
40,42
 In the fibroblasts we studied, the sphingolipid-enriched 
plasma membrane domains were regulated by the cytoskeleton, and cohesive cholesterol-
sphingolipid interactions (not shown) were insufficient to drive the cholesterol to associate with 
the sphingolipid domains. Based on these findings, and the presence of a cytoskeleton in all 
mammalian cells, we anticipate that the plasma membranes of most types of mammalian cells 
contain sphingolipid domains that are not enriched with cholesterol, although the sizes of these 
domains may vary.  
By supplementing fluorescence microscopy studies with our complementary high-
resolution SIMS imaging of isotope-labeled lipids in the plasma membrane, the mechanism that 
links lipid organization to the cytoskeleton and the role of cholesterol in this process may be 
elucidated.  
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Figures and Tables 
 
Figure 3.1 Secondary electron images of a Clone 15 fibroblast cell were acquired in parallel with 
the secondary ion signals, using NanoSIMS. Montage of 15 × 15-μm secondary electron images 
shows the morphology of a representative Clone 15 cell. 
  
76 
 
Figure 3.2 Montage of 
15
N-enrichment images shows the 
15
N-sphingolipid distribution on the 
Clone 15 fibroblast cell. The color scale represents the measured 
12
C
15
N
−
/
12
C
14
N
−
 ratio divided 
by the natural abundance ratio, corresponding to the 
15
N-sphingolipid enrichment. The mean 
15
N-
enrichment factors for domain-free regions and the entire cell are 7.8 (open arrowhead, SD = 2.1) 
and 9.5 (solid arrowhead, SD = 3.6), respectively. Lateral variations in the 
15
N-sphingolipid 
abundance are visible. Consistent with reports that fibroblasts deposit membrane fragments when 
migrating, 
15
N-sphingolipid–enriched debris is present on the substrate.{Regen, 1992 #922} The 
enlarged views of the secondary electron, 
13
C-enrichment, and 
15
N-enrichment images that were 
acquired at the outlined region on the cell (Inset) demonstrate that the 
15
N-sphingolipid domains 
do not coincide with cell topography or excess cellular lipids. The color scale for the 
13
C-
enrichment image shown in the Inset is provided in Figure 3.3. 
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Figure 3.3 
13
C-enrichment images of a Clone 15 fibroblast cell were acquired in parallel with the 
secondary electron (Fig. 3.1) and 
15
N-enrichment (Fig. 3.2) images. Montage of quantitative 
13
C-
enrichment images reveals the distribution of all lipids in the plasma membrane of the Clone 15 
cell. The color scale shows the measured 
13
C
1
H
−
/
12
C
1
H
−
 ratio divided by the natural abundance 
ratio, corresponding to the 
13
C-lipid enrichment. The mean 
13
C-enrichment for the entire surface 
of the cell was 16.3 (arrowhead, SD = 22.5). The elevated 
13
C-enrichment and the absence of 
statistically significant lateral variations in the 
13
C-enrichment on the cell verify the plasma 
membrane was intact. Speckling is due to low counts of the CH isotopologues.  
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Table 3.1 Characteristics of cell membrane area and sphingolipid domains in Clone 15 cells 
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 Figure 3.4. Three-
dimensional 
distribution of 
13
C-
enrichment in the cell 
shows elevated 
13
C-
enrichment is specific 
to cellular membranes. 
(A) A series of 36 
NanoSIMS 
13
C-
enrichment images 
were sequentially 
acquired at the same 
sample position on a 
representative Clone 15 
cell that was 
metabolically labeled 
and prepared for 
analysis identically to 
the cells shown above. 
To permit analysis of 
the cytoplasm, the 
NanoSIMS operating 
conditions used to 
acquire these images 
were adjusted so that 
the sampling depth was 
approximately four 
times greater than that 
used to acquire the rest 
of the NanoSIMS images presented herein. Approximately 1.3 nm of material was sputtered 
from the sample surface each time an image was acquired. The elevated 
13
C-enrichment was 
continuous at the cell surface, but became discontinuous upon the detection of significant 
amounts of material within the cytoplasm. Once most of the plasma membrane had been 
removed (approximately image 6), the 
13
C-enrichment was elevated only at localized regions 
within the cytoplasm that likely correspond to organelle membranes and lipid-containing 
organelles. This confirms that elevated 
13
C-enrichment is characteristic of cellular membranes. In 
addition, inspection of the 
13
C-lipid structures in the cytoplasm shows that their edges remain 
sharp as the analysis depth increases, which demonstrates that NanoSIMS analysis did not induce 
biomolecule mixing or alter the lateral distribution of lipids in the sample. Similar results were 
obtained by depth-profiling measurements made on the four other cells we analyzed. (B) The 
morphology of the cell is shown in the NanoSIMS secondary electron (SE) image of this 
location. SEs were not detected at the lower portion of the image, likely because secondary 
electron production is low when the low primary ion beam currents are used for imaging. 
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Figure 3.5 NanoSIMS images of three additional Clone 15 cells that were fixed with 
glutaraldehyde at 37 °C. The montages of secondary electron images show Clone 15 cell 1 at 
37°C (A), cell 2 at 37 °C (C), and cell 3 at 37 °C (D) have normal morphology. The 
15
N-
enrichment images show the 
15
N-sphingolipid abundance in the membranes of Clone 15 cell 1 at 
37 °C (B), cell 2 at 37 °C (E), and cell 3 at 37 °C (F). Color scale is the
12
C
15
N
−
/
12
C
14N−ratio 
divided by the natural abundance ratio. For cell 1 at 37 °C, the mean 
15
N-enrichment factors for 
the entire surface and the domain-free regions on the cell are 9.2 (solid arrowhead, SD = 4.8) and 
7.4 (open arrowhead, SD= 2.8), respectively. For cell 2 at 37 °C, the mean15 N-enrichment 
factors for the entire surface (solid arrowhead) and domain-free areas (open arrowhead) are 8.5 
(SD = 4.6) and 5.1 (SD = 1.9), respectively. For cell 3 at 37 °C, the mean 15 N-enrichment 
factors for the entire surface (solid arrowhead) and domain-free areas (open arrowhead) are 6.3 
(SD = 3.4) and 5.6 (SD = 2.4), respectively. 
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Figure 3.6  Sphingolipid-
enriched domain size and 
spatial distribution. (A) White 
outlines show the perimeters 
of the 
15
N-sphingolipid 
domains (defined with a 
particle definition algorithm) 
in a portion of the 
15
N-
enrichment image shown in 
Fig. 3.2. (B and C) The 
locations of the 
15
N-
sphingolipid domains are 
outlined on the corresponding 
(B) secondary electron image 
(black) and (C) 
13
C-
enrichment image (white). 
(D) The frequency 
distributions of sphingolipid 
domain sizes measured on 
cells fixed with 
glutaraldehyde solution at 
either RT or 37 °C or treated 
with mβCD show these 
treatments did not affect 
microdomain size. (E) Plot of 
Ripley’s K-test statistic, L(r) 
– r, as a function of distance. 
Data are normalized so the 
99% CI (CI 99, dashed line) = 
1. L(r) – r exceeds the CI 99 for all accessible distances >0.2 μm regardless of fixation 
temperature, signifying nonrandom microdomain clustering. mβCD treatment decreased domain 
clustering at distances >2 μm. (F) Plot of the difference between the frequency distribution of 
nearest neighbor (NN) domain distances measured for the observed (expt) domains (Inset) and a 
simulated (sim) random domain distribution on the cell body vs. distance. For all treatments, NN 
distances of ∼200 nm occurred more often than expected for a random distribution. (G) 
Difference in the pairwise domain distances (PD) measured for the observed and simulated 
randomly distributed domains is plotted as a function of distance. For both fixation temperatures, 
the higher occurrence of domain–domain distances between 5 and 10 μm than expected for 
randomly distributed domains (Inset) indicates the microdomain clusters were more abundant 
within 5- to 10-μm diameter patches on the cell body. Treatment with mβCD disrupted this long-
range microdomain organization.   
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Figure 3.7 Secondary electron, 
15
N-enrichment, and 
13
C-enrichment images of a Clone 15 cell 
that was treated with latrunculin A for 30 min to disrupt the cytoskeleton. (A) Montage of 
secondary electron images acquired with NanoSIMS shows the extensive cell rounding that is 
characteristic of cytoskeleton disruption by latrunculin A treatment. (B) Montage of 
15
N-
enrichment images of the same cell shows that micrometer-scale sphingolipid domains were not 
present on the cell surface after disruption of the cytoskeleton by treatment with latrunculin A. A 
few micrometer-scale 
15
N-sphingolipid aggregates are present on the cellular extensions adjacent 
to the rounded cell body (outlined with a dashed white line). (C) Montage of 
13
C-enrichment 
images shows the 
13
C-lipid distribution at the same location. The high 
13
C-enrichment on the 
substrate adjacent to the cell likely signifies the presence of membrane fragments.   
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Figure 3.8  High-resolution SIMS images of a NIH 3T3 cell treated with latrunculin A to disrupt 
its cytoskeleton. (A) montage of secondary electron images acquired with high-resolution SIMS 
shows latrunculin A treatment disrupted the cytoskeleton of the metabolically labeled NIH 3T3 
cell. Secondary electrons were not detected near the bottom of the image due to the low primary 
ion beam current used for analysis. (B) montage of 
15
N-enrichment SIMS images shows few 
15
N-
sphingolipid domains were present in the plasma membrane of the NIH 3T3 cell after latrunculin 
A treatment. Latrunculin A treatment also disrupts the sphingolipid domains in the plasma 
membranes of clone 15 cells. 
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CHANGES IN SPHINGOLIPID MICRODOMAINS AS A FUNCTION OF TIME 
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Introduction 
Being the outermost structure of mammalian cells, the plasma membrane is involved  in 
many key cellular functions.
1–4
 Because of the membrane’s importance in multiple cellular 
processes, many studies have focused on elucidating plasma membrane organization and how 
this organization changes in response to internal and external stimuli, such as protein signaling, 
cholesterol depletion, and mutations in integral membrane proteins.
5–9
 Despite being intensely 
researched, the organization of most lipid species within the plasma membrane, sphingolipids 
being of particular interest, has been difficult to determine.
10
  
As was described in the previous chapters, we have used high-resolution imaging 
secondary ion mass spectrometry (SIMS) to image metabolically incorporated 
15
N-sphingolipids 
in the plasma membranes of mouse fibroblast cells that stably expressed influenza hemagglutinin 
(Clone 15 cell line).
11
 In these experiments, the cells were first metabolically labeled for 6 days 
so that the resulting 
15
N-sphingolipids reached a steady-state intracellular distribution. High-
resolution SIMS mapping of the sphingolipid-specific 
15
N-enrichment on the cell surface (top ~5 
nm) revealed micrometer-scale 
15
N-sphingolipid patches consisting of many sphingolipid 
microdomains (~200 nm in diameter) that were detectable in the plasma membrane.
11
  The sizes 
of these domains, and their higher dependency on the cytoskeleton than on cholesterol 
abundance, indicated the sphingolipids were confined within domains by the cytoskeleton and its 
associated proteins.
11
 The relatively even cholesterol distribution (not shown in this dissertation) 
subsequently observed in the plasma membranes of Clone 15 cells and analogous mouse 
fibroblast cells (NIH-3T3, the parent line from which Clone 15 was derived) confirmed that the 
sphingolipid domains did not result from favorable cholesterol-sphingolipid interactions.
12
 
Instead, these results are consistent with the hypothesis that cortical actin and its associated 
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proteins establish diffusion barriers that sustain concentration gradients produced by vesicle 
transport.
13
 In this hypothesis, cortical actin and its associated proteins establish diffusion 
barriers that sustain local concentration gradients produced by vesicle fusion.
13
 Consequently, 
the local elevations in sphingolipid abundance that we have observed within the plasma 
membrane may result from the fusion of the transport vesicles that move newly synthesized 
sphingolipids from the Golgi apparatus to the plasma membrane.    
In this chapter, we investigate how newly biosynthesized sphingolipids are organized in 
the plasma membrane. We pulse labeled the cells with 
15
N-sphingoid bases for time intervals that 
ranged from 30 min to 6 d and imaged the distributions of the 
15
N-sphingolipids that were 
synthesized from these labeled 
15
N-sphingoid bases in the plasma membrane with high-
resolution SIMS. We found that the newly synthesized 
15
N-sphingolipids were rapidly 
incorporated into discrete domains within the plasma membrane. The fraction of the plasma 
membrane that was occupied by domains that are enriched with 
15
N-sphingolipids was fairly 
constant for all pulse labeling times employed, though the 
15
N-enrichment, and thus the amount 
of 
15
N-sphingolipids, within these domains increased with the pulse labeling time. The short 
range (<1 μm) sphingolipid microdomain organization did not change as the pulse labeling time 
increased. The long range (>2 μm) sphingolipid microdomain organization slightly increased as 
the pulse labeling time increased to 8 h, and no further changes were observed at longer labeling 
times.  These results indicate that the 
15
N-sphingolipids synthesized from the 
15
N-sphingoid 
bases were rapidly incorporated into plasma membrane domains with sphingolipids that 
contained the unlabeled (abundant nitrogen-14 isotope) sphingoid backbone. These findings 
suggest that the sphingolipids in the plasma membrane are rapidly internalized, are sorted to the 
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Golgi or endosomes where they mix with newly synthesized sphingolipids before returning to 
the plasma membrane.    
Methods 
Materials  
The Clone 15 cell line, transfected from the NIH-3T3 mouse fibroblast line to stably 
express the influenza protein hemagglutinin, was obtained from the NIH (Zimmerberg). Initial 
cell growth medium (Media A) consisted of high glucose Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10% Hyclone calf serum (Fisher Scientific), 10
4
 U/mL penicillin G, 
and 10 mg/mL streptomycin. During the second stage of cell growth, the medium (Media B) 
consisted of high glucose DMEM supplemented with 10% Hyclone lipid-reduced fetal bovine 
serum and 1% Hyclone calf serum (Fisher Scientific). A fatty acid solution (
13
C-fatty acids) 
made from algal lipid mixture (uniformly carbon-13 labeled, UL-
13
C, 98%+) (Cambridge Isotope 
Laboratories, Inc.), stearic acid (
13
C18, 99 atom% 
13
C) (Isotec), and fatty acid free bovine serum 
albumin (FAF-BSA) was used to metabolically label all cellular lipids. The 
15
N-sphingoid bases,
 
1:1 molar ratio of 
15
N-sphingosine and 
15
N-sphinganine, used to isotopically label sphingolipids 
consist were synthesized from 
15
N-serine following reported techniques.
14–16
 Natural abundance 
(NA-) sphingoid bases were synthesized in the same manner using regular serine. Silicon 
substrates (5 x 5 mm) were purchased from Ted Pella, Inc. Separation and mass spectrometry 
(MS) was performed using an Agilent 1100 LC/MSD Trap XCT Plus equipped with a 
Phenomenex Gemini 3u C6-Phenyl 110A column (2 x 100 mm) (LC-MS) and an Agilent 6890 
gas chromatograph with a ZB-WAX (30 m × 0.25 mm I.D., 0.25 m film thickness) capillary 
column (Phenomenex, Torrance, CA, USA), an Agilent 5973 mass selective detector and HP 
7683B (Agilent Inc, Palo Alto, CA, USA) autosampler (GC-MS). 
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Metabolic Labeling  
Cells were grown in Media A at 37°C in 5% CO2 during which culture media was 
supplemented with 3 µM
 
NA-sphingoid bases on a daily basis. After 3 nights, the cells were 
passaged, plated onto new culture dishes, and grown in Media B at 37°C in 5% CO2. On a daily 
basis, Media B was supplemented with 3 µM
 
NA-sphingoid bases and 227 µM 
13
C-fatty acids 
(4:1:28 mass ratio of UL-
13
C lipid mix/
13
C-stearic acid/FAF-BSA). On the sixth day, cells were 
passaged and reset into dishes containing fresh Media B, NA-sphingoid bases and 
13
C-fatty acid 
supplements, and sterilized, poly-L-lysine coated silicon substrates. The following day, culture 
media was removed and replaced with fresh Media B. The fresh media was then supplemented 
with 227 µM 
13
C-fatty acids and 6 µM
 15
N-sphingoid bases. After pre-determined time intervals, 
substrates with attached cells were collected and chemically fixed. The remaining cells attached 
to the culture dishes were harvested and further used for label incorporation evaluation. 
15
N-Incorporation Analysis  
The harvested cells underwent lipid extraction.
17,18
 LC-MS was performed and ion peaks 
corresponding to N-palmitoyl sphingomyelin, including m/z 703.6 (unlabeled N-palmitoyl 
sphingomyelin), 704.6 (
15
N-palmitoyl sphingomyelin), 719.6 (
14
N-palmitoyl 
13
C16-
sphingomyelin), 720.6 (
15
N-palmitoyl 
13
C16-sphingomyelin), and 735.7 (
14
N-palmitoyl 
13
C32-
sphingomyelin), were analyzed to determine the percent incorporation of nitrogen-15 into 
sphingolipid molecules.  The contribution from other isotopologues was removed, and the 
fraction of N-palmitoyl sphingomyelin that contained the nitrogen-15 isotope was calculated as 
the ratio of 
15
N-palmitoyl sphingomyelin and 
15
N-palmitoyl 
13
C16-sphingomyelin peak intensities 
to the sum of the peak intensities from all N-palmitoyl sphingomyelin isotopologues. The 
fraction of N-palmitoyl sphingomyelin that biosynthesized from uniformly labeled 
13
C-palmitic 
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acid was also calculated as the ratio of the sum of 
14
N-palmitoyl 
13
C16-sphingomyelin, 
15
N-
palmitoyl 
13
C16-sphingomyelin, and 
14
N-palmitoyl 
13
C32-sphingomyelin over the sum of all of the 
peaks. 
13
C-Incorporation Analysis  
The lipid extracts were hydrolyzed, neutralized, and methylated. GC-MS was then 
performed on the resulting fatty acid methyl esters (FAMEs). The signal intensities 
corresponding to 
13
C16-palmitic acid (m/z 286), 
12
C16-palmitic acid (m/z 270), 
13
C16-palmitoleic 
acid (m/z 284), 
12
C16- palmitoleic acid (m/z 268), 
13
C18-stearic acid (m/z 316), 
12
C18-stearic acid 
(m/z 298), 
13
C18-oleic acid (m/z 314),
 12
C18-oleic acid (m/z 296),
 13
C18-linoleic acid (m/z 312), and 
12
C18-linoleic acid (m/z 294) were then used to determine a representative incorporation value. 
Cell Preservation  
Silicon chips were removed from culture dishes and rinsed with Hendry’s Phosphate 
Buffer (HPB). Cells were fixed in 4% glutaraldehyde (diluted in HPB) for 30 min at room 
temperature. Substrates were then rinsed twice in HPB for 5 min followed by one rinse in 18mΩ 
filtered water. Heavy metal staining was then performed using 1% osmium tetroxide solution for 
15 min. Samples were then rinsed three times for 5 min each in 18mΩ filtered water and allowed 
to air dry. 
Pre-Characterization of Cells  
An optical map showing the locations of cells in relation to one another, the scratches on 
the chip, and the edges of the chip was created using bright field microscopy.  Secondary 
electron microscopy (SEM) was performed on a Hitachi S4800 SEM instrument. Since the 
samples did not receive a sputter coating, SEM was performed using low voltage in order to 
avoid sample charging and to prevent damage to the sample. 
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High-Resolution Secondary Ion Mass Spectrometry (SIMS)  
High-resolution SIMS was performed on a Cameca NanoSIMS 50 (Cameca, France) at 
Lawrence Livermore National Laboratory similarly to how was previously reported. To increase 
signal and prevent charging, samples were sputter coated with 3 nm of iridium. A ~0.15 pA 
133
Cs
+
 primary ion beam was used for an analysis that included four replicate scans of 512 x 512 
pixels, with a dwell time of 1000 µs/pixel, over a 15 x 15 µm
2
 analysis region, resulting in a 
pixel size of 29 x 29 nm
2
. The 
12
C
12
C
-
, 
13
C
12
C
-
, 
12
C
14
N
-
, and 
12
C
15
N
-
 secondary ions, and 
secondary electrons were simultaneously collected.  
Image Processing  
Image analysis was performed using a custom software package (L’image, L.R. Nittler, 
Carnegie Institution of Washington) run on a PV-Wave platform (Rogue Wave Software). The 
distribution of each labeled cell component was determined according to the isotopic enrichment 
for that species, which is the ratio of secondary ion signal intensities of the rare isotope to its 
corresponding naturally abundant isotope, 
13
C
12
C
-
/
12
C
12
C
-
 correlating to all 
13
C-cellular lipids 
while 
15
N
12
C
-
/
14
N
12
C
-
 corresponds to 
15
N-sphingolipids, divided by the natural abundance ratio 
(0.00367 and 0.011237 respectively). This resulted in the number of times that the enrichment is 
great than that in an unlabeled cell.  
Quantitative Analysis of 
15
N-enriched Sphingolipid Domains  
For each cell, the threshold 
15
N-enrichment that is statistically significant and cannot be 
attributed to noise was identified using the MATLAB Statistics Toolbox
TM
, as previously 
reported (1). The regions of statistically significant 
15
N-enrichment that represent 
15
N-
sphingolipid domains on each cell were defined with a particle definition algorithm within a 
custom software package (Limage; L. R. Nittler, Carnegie Institution of Washington, 
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Washington, DC) run on the PV-Wave platform (Rogue Wave), as described previously.
11
 The 
spatial arrangements of the 
15
N-sphingolipid domains on each cell were evaluated using the 
SpatStat spatial statistics package run in the R program as previously reported.
11,19
 
Results 
Incorporation of 
15
N-Sphingolipids into Cells after Various Pulse Labeling Times 
We investigated Clone 15 cells that had been pulse-labeled with the 
15
N-sphingolipid 
precursors, 
15
N-sphingosine and 
15
N-sphinganine, for times varying from 30 min to 24 h. These 
intervals are much shorter than the 6 d labeling time that we previously used to produce a steady-
state 
15
N-sphingolipid distribution in the plasma membrane.
11
  Cells that had been cultured in the 
presence of 
15
N-sphingolipid precursors for 6 d were also characterized to permit comparison to 
the steady state sphingolipid organization. To help ensure that the cells are able to rapidly utilize 
the 
15
N-sphingoid bases for sphingolipid biosynthesis while maintaining sphingolipid 
homeostasis, the cells were cultured in the presence of unlabeled sphingoid bases for 6 d prior to 
pulse labeling. 
Liquid chromatography-mass spectrometry (LC-MS) measurements revealed a gradual 
increase in 
15
N-sphingoid base incorporation into N-palmitoyl sphingomyelin, the most abundant 
cellular sphingolipid (Table 4.1).  These measurements indicated that the 
15
N-sphingoid base was 
incorporated into approximately 8% of the N-palmitoyl sphingomyelin detected in cells that were 
pulse-labeled for 30 min, 1 h, and 2 h. However, these 
15
N-incorporation levels are likely 
overestimated because it is difficult to remove the contributions of unlabeled lipid species from 
the peaks that are used to quantify the 
15
N-sphingomyelin species when the 
15
N-incorporation is 
low. The 
15
N-incorporation gradually increased from approximately 8% to 37% as the pulse 
labeling interval increased from 2 to 24 h (Table 4.1).  In comparison, 
15
N-incorporation into the 
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N-palmitoyl sphingomyelin was 89% in the cells that had been pulse labeled for 6 d. Thus, these 
results suggest that under these conditions, the majority of the cellular sphingolipids were either 
degraded to non-sphingolipid products between 24 h and 6 d.    
The relative 
15
N-sphingolipid abundance within the plasma membrane was assessed by 
using high-resolution SIMS to measure the 
15
N-enrichment, which is the number of times the 
15
N-enrichment is greater than the standard abundance ratio (0.00367), on the cell surface (top ≤5 
nm). The mean 
15
N-enrichment measured in the plasma membranes of the labeled cells gradually 
increased from 2.4 to 19.7 as the pulse labeling time increased from 0.5 h to 6 d. The slight 
decrease in the mean 
15
N-enrichment measured in the plasma membrane observed when the 
pulse labeling time increased from 12 to 24 h likely indicates the label abundance in the 
extracellular media, which was added to the culture every 24 h, had become depleted by the end 
of the 24 h labeling period.  
Characteristics of the Individual 
15
N-Sphingolipid Microdomains Produced by Various Pulse 
Labeling Times  
The 
15
N-enrichment images acquired with high-resolution SIMS revealed domains of 
elevated 
15
N-sphingolipid distribution in the plasma membrane after each pulse labeling time 
(Figure 4.1). Visual inspection of the images suggested that the 
15
N-enrichment, and thus 
15
N-
sphingolipid abundance, within the domains generally increased with pulse labeling time. 
Quantitative analysis of the SIMS images (see Materials and Methods for details) confirmed this 
deduction. Though the mean 
15
N-enrichment measured in the 
15
N-sphingolipid domains and 
nondomain regions on the cells were highly variable at all labeling times, they generally 
increased as the pulse labeling time increased up to 12h (Table 4.1). In contrast, the 
microdomains’ sizes and abundances on the cell surface were less dependent on the pulse 
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labeling time. The mean effective diameter, which is defined as the diameter of a circular domain 
with the same area, of the 
15
N-sphingolipid domains increased as the pulse labeling time 
increased from 30 min to 2 h. However, only small increases in domain size were observed as 
the pulse labeling time increased beyond 2 h (Table 4.1). Pulse labeling time did not seem to 
affect the percentage of the cell’s surface that was covered by sphingolipid-enriched 
microdomains, which was between approximately 10 to 15% for all labeling times.  Altogether, 
these data suggest that within 2 h, nearly all of the sphingolipid domains in the plasma 
membrane contained a mixture of newly synthesized 
15
N-sphingolipids and pre-existing, 
endogenous (naturally abundant nitrogen-14 containing) sphingolipids.    
Effects of Pulse Labeling Time on 
15
N-Sphingolipid Microdomain Organization 
Established statistical methods for point pattern analysis
12,19,20
 were used to assess 
whether the duration of 
15
N-sphingolipid precursor incorporation into the cells affected the 
organization of the 
15
N-sphingolipid microdomains in the plasma membrane. The coordinates for 
the centers of the 
15
N-sphingolipid microdomains with respect to the surface of each cell were 
tabulated, and then a modified Ripley’s K-test was performed to assess whether the microdomain 
organization deviated from a random distribution.
12,19
 Figure 4.2A shows the average Ripley's K-
test statistic, L(r) – r, for 3 to 6 cells that were pulse labeled for the indicated duration as a 
function of radial distance; the plots were normalized so that the 99% confidence interval (99% 
CI) equals one.  For all labeling times, the average L(r) – r was larger than the 99% CI at radial 
distances between ~0.2 and the longest accessible length scale (~3 μm), indicating the 15N-
sphingolipid microdomains were non-randomly clustered over this distance.   
To examine whether the pulse labeling time influenced the 
15
N-sphingolipid 
microdomain clustering, we compared the frequencies of domain-domain distances for the 
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microdomains observed on the pulse labeled cells to those for simulated populations of randomly 
positioned domains. The nearest neighbor (NN) distance, which is the distance between the 
center of each domain and that of its closest neighbor, provides information on the short-range 
microdomain organization. Figure 4.2B shows the average differences between the frequencies 
of observed and simulated NN distances that were calculated using data from 3 – 6 cells that 
were pulse labeled for the indicated time.  For all labeling times, NN distances of 200 nm 
occurred more frequently than expected for randomly positioned microdomains. Because the 
average microdomain diameters were between 130 to 180 nm, the microdomains were nearly 
touching their nearest neighbor.  
The pairwise domain (PD) distances, which are the distances between the center of each 
sphingolipid microdomain and every other microdomain on the cell, provides information on 
whether the sphingolipid microdomains form larger clusters in the plasma membrane. For each 
labeling time, the frequencies of observed and simulated PD distances were tabulated using data 
from 15 µm by 15 µm regions on 2 – 4 cells, and the average difference between the frequencies 
of observed and simulated PD distances was calculated over then range of 0 to 20 µm. The 
trends in the plots of the average fractional difference in the observed and simulated PD 
distances reveal modest changes in sphingolipid microdomain organization in the cells measured 
for 4 h or less versus those labeled for longer durations (Figure 4.2C).  For cells pulse labeled for 
4 h or less, PD distances in the range of 0.5 to 5 μm and also 10 to 18 nm occurred more 
frequently than expected for a randomly distributed population, whereas PD distances between 5 
and 10 μm occurred less frequently than expected. This indicates the sphingolipid microdomains 
in the plasma membranes of cells that were pulse-labeled for no more than 4 h were 
nonrandomly clustered within membrane regions that were roughly 5 μm across, and these 
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patches of microdomains were separated from one another by approximately 10 – 18 µm.  In 
comparison, for cells that were pulse labeled for at least 8 h the difference in the observed and 
simulated PD distances were generally positive at distances of 0.5 to 6 μm, somewhat negative at 
distances of 9 to 15 µm, and near zero at distances of 16 – 20 µm.  These data suggest that the 
sphingolipid microdomains nonrandomly clustered within marginally larger membrane patches 
that were slightly more separated from each other when the pulse labeling increased to 8 h. 
Altogether, these results indicate both the short and long range sphingolipid distribution within 
the plasma membrane occurs very rapidly.   
Discussion 
Our data indicates sphingolipid organization in the plasma membrane arises from the 
effects of the cytoskeleton and intracellular traffic, specifically that of the cortical actin and its 
associated proteins establishing diffusion barriers that sustain local concentration gradients 
produced by vesicle fusion.
13
 Consequently, the fusion of transport vesicles that move newly 
synthesized sphingolipids from the Golgi to the plasma membrane produces local elevations in 
sphingolipid abundance within the plasma membrane.  
De novo sphingolipid biosynthesis begins in the endoplasmic reticulum with the 
condensation of serine and palmitoyl-CoA. Ensuing steps in the endoplasmic reticulum yield the 
sphingoid base, sphinganine, which is converted to ceramide. The ceramide is then transported to 
the Golgi, where it is converted to complex sphingolipids, including sphingomyelin and 
glycosphingolipids. These sphingolipid products are packaged into vesicles that are transported 
to the plasma membrane.   The fusion of these sphingolipid-rich vesicles with the plasma 
membrane would then produce local elevations in sphingolipid abundance. These elevations 
persist due to the diffusion barriers established by a dense network of transmembrane proteins 
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that are tethered to the underlying cytoskeleton. Sphingolipids in the plasma membrane are 
internalized to endososomes where they can be transported back to the plasma membrane, or 
degraded in lysosomes. Sphingolipids that are recycled back to the plasma membrane may utilize 
a direct route, or they may be first sent to the Golgi where they would be packaged into transport 
vesicles that also contain newly synthesized sphingolipids, and then trafficked together to the 
plasma membrane.  Alternatively the sphingolipids that are destined for degradation in 
lysosomes are broken down to sphingosine. Although sphingosine is not produced in the de novo 
sphingolipid biosynthesis pathway, the resulting sphingosine can be transported to the 
endoplasmic reticulum, and reutilized for sphingolipid biosynthesis via the salvage pathway. 
In this work, only the sphingolipids that contain the 
15
N-sphingoid backbone could be 
detected with high-resolution SIMS. Our findings of little change in either the fraction of the cell 
membrane’s surface that was covered with 15N-sphingolipid microdomains, or the size of these 
15
N-sphingolipid microdomains indicates most sphingolipids in the plasma membrane were 
endocytosed, transported to intracellular compartments where they mixed with newly 
synthesized sphingolipids, and then returned to the plasma membrane. Once returning to the 
plasma membrane, vesicles containing these newly synthesized sphingolipids formed statistically 
significant (as determined using the MATLAB Statistics Toolbox
TM
) and  non-randomly 
clustered  sphingolipid domains (calculated using Ripley’s K-test). This non-random distribution 
was also confirmed when evaluating the nearest neighbor (NN) distances of the observed 
sphingolipid domains at which point it was determined that most domains were nearly touching 
their nearest neighbot. Finally, steady state distribution in the plasma membrane was assessed by 
comparing the pairwise domain distances; results indicate that both the short and long range 
sphingolipid distribution within the plasma membrane is established very quickly.   
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The use of high-resolution SIMS in conjunction with a pulse-labeling of cellular 
sphingolipids provided us with a better understanding of the analyzed murine fibroblast cells. 
New insight was gained in terms of the speed in which these cells will turnover their membrane 
surface (noticeable changes occurring within 30 min). This work also points towards the 
importance of vesicle transport within domain formation since the primary path for sphingolipid 
delivery to the plasma membrane is via vesicles.
21,22
 The appearance of sphingolipid domains at 
all of our time points indicates that large portions of newly synthesized sphingolipids are quickly 
delivered to the plasma membrane, possibly in vesicles that fuse to adjacent regions within the 
plasma membrane. While unique insight has been gained towards better understanding 
sphingolipid delivery into domains, further studies will need to be conducted in order to fully 
understand the role that vesicle transport plays in the formation of sphingolipid domains. 
  
98 
 
References 
(1)  Doherty, G. J.; McMahon, H. T. Mediation, Modulation, and Consequences of 
Membrane-Cytoskeleton Interactions. Annu. Rev. Biophys. 2008, 37 (1), 65–95. 
 
(2)  Holthuis, J. C. M.; Levine, T. P. Lipid Traffic: Floppy Drives and a Superhighway. Nat. 
Rev. Mol. Cell Biol. 2005, 6 (3), 209–220. 
 
(3)  Shaw, J. E.; Epand, R. F.; Epand, R. M.; Li, Z.; Bittman, R.; Yip, C. M. Correlated 
Fluorescence-Atomic Force Microscopy of Membrane Domains: Structure of 
Fluorescence Probes Determines Lipid Localization. Biophys. J. 2006, 90 (6), 2170–
2178. 
 
(4)  Zhang, J.; Pekosz, A.; Lamb, R. A. Influenza Virus Assembly and Lipid Raft 
Microdomains: A Role for the Cytoplasmic Tails of the Spike Glycoproteins. J. Virol. 
2000, 74 (10), 4634–4644. 
 
(5)  Eggeling, C.; Ringemann, C.; Medda, R.; Schwarzmann, G.; Sandhoff, K.; Polyakova, S.; 
Belov, V. N.; Hein, B.; von Middendorff, C.; Schoenle, A.; et al. Direct Observation of 
the Nanoscale Dynamics of Membrane Lipids in a Living Cell. Nature 2009, 457 (7233), 
1159–U121. 
 
(6)  Shnyrova, A. V.; Frolov, V. A.; Zimmerberg, J. Domain-Driven Morphogenesis of 
Cellular Membranes. Curr. Biol. 2009, 19 (17), R772–R780. 
 
(7)  Simons, K.; Toomre, D. Lipid Rafts and Signal Transduction. Nat. Rev. Mol. Cell Biol. 
2000, 1 (1), 31–39. 
 
(8)  Takeda, M.; Leser, G. P.; Russell, C. J.; Lamb, R. A. Influenza Virus Hemagglutinin 
Concentrates in Lipid Raft Microdomains for Efficient Viral Fusion. Proc. Natl. Acad. 
Sci. 2003, 100 (25), 14610–14617. 
 
(9)  Radhakrishnan, K.; Halasz, A.; Vlachos, D.; Edwards, J. S. Quantitative Understanding 
of Cell Signaling: The Importance of Membrane Organization. Curr. Opin. Biotechnol. 
2010, 21 (5), 677–682. 
 
(10)  Jacobson, K.; Mouritsen, O. G.; Anderson, R. G. W. Lipid Rafts: At a Crossroad between 
Cell Biology and Physics. Nat. Cell Biol. 2007, 9 (1), 7–14. 
 
(11)  Frisz, J. F.; Lou, K.; Klitzing, H. A.; Hanafin, W. P.; Lizunov, V.; Wilson, R. L.; 
Carpenter, K. J.; Kim, R.; Hutcheon, I. D.; Zimmerberg, J.; et al. Direct Chemical 
Evidence for Sphingolipid Domains in the Plasma Membranes of Fibroblasts. Proc. Natl. 
Acad. Sci. 2013, 110 (8), E613–E622. 
 
(12)  Frisz, J. F.; Klitzing, H. A.; Lou, K.; Hutcheon, I. D.; Weber, P. K.; Zimmerberg, J.; 
Kraft, M. L. Sphingolipid Domains in the Plasma Membranes of Fibroblasts Are Not 
Enriched with Cholesterol. J. Biol. Chem. 2013, 288 (23), 16855–16861. 
99 
 
 
(13)  Kusumi, A.; Nakada, C.; Ritchie, K.; Murase, K.; Suzuki, K.; Murakoshi, H.; Kasai, R. 
S.; Kondo, J.; Fujiwara, T. Paradigm Shift of the Plasma Membrane Concept from the 
Two-Dimensional Continuum Fluid to the Partitioned Fluid: High-Speed Single-
Molecule Tracking of Membrane Molecules. In Annual Review of Biophysics and 
Biomolecular Structure; Annual Reviews: Palo Alto, 2005; Vol. 34, pp 351–U54. 
 
(14)  Garner, P.; Park, J. M.; Malecki, E. A Stereodivergent Synthesis of D-Erythro-
Sphingosine and D-Threo-Sphingosine from L-Serine. J. Org. Chem. 1988, 53 (18), 
4395–4398. 
 
(15)  Dondoni, A.; Perrone, D. Synthesis of 1,1-Dimethylethyl (S)-4-Formyl-2,2-Dimethyl-3-
Oxazolidinecarboxylate by Oxidation of the Alcohol. In Organic Syntheses; John Wiley 
& Sons, Inc., 2003. 
 
(16)  Peters, C.; Billich, A.; Ghobrial, M.; Högenauer, K.; Ullrich, T.; Nussbaumer, P. 
Synthesis of Borondipyrromethene (BODIPY)-Labeled Sphingosine Derivatives by 
Cross-Metathesis Reaction. J. Org. Chem. 2007, 72 (5), 1842–1845. 
 
(17)  Klitzing, H. A.; Weber, P. K.; Kraft, M. L. Secondary Ion Mass Spectrometry Imaging of 
Biological Membranes at High Spatial Resolution. In Nanoimaging; Sousa, A. A., 
Kruhlak, M. J., Eds.; Humana Press: Totowa, NJ, 2013; pp 483–501. 
 
(18)  Bligh, E. G.; Dyer, W. J. A Rapid Method of Total Lipid Extraction and Purification. 
Can. J. Biochem. Physiol. 1959, 37 (8), 911–917. 
 
(19)  Hess, S. T.; Kumar, M.; Verma, A.; Farrington, J.; Kenworthy, A.; Zimmerberg, J. 
Quantitative Electron Microscopy and Fluorescence Spectroscopy of the Membrane 
Distribution of Influenza Hemagglutinin. J. Cell Biol. 2005, 169 (6), 965–976. 
 
(20)  Zhang, J.; Leiderman, K.; Pfeiffer, J. R.; Wilson, B. S.; Oliver, J. M.; Steinberg, S. L. 
Characterizing the Topography of Membrane Receptors and Signaling Molecules from 
Spatial Patterns Obtained Using Nanometer-Scale Electron-Dense Probes and Electron 
Microscopy. Micron 2006, 37 (1), 14–34. 
 
(21)  Gheber, L. A.; Edidin, M. A Model for Membrane Patchiness: Lateral Diffusion in the 
Presence of Barriers and Vesicle Traffic. Biophys. J. 1999, 77 (6), 3163–3175. 
 
(22)  Klemm, R. W.; Ejsing, C. S.; Surma, M. A.; Kaiser, H.-J.; Gerl, M. J.; Sampaio, J. L.; 
Robillard, Q. de; Ferguson, C.; Proszynski, T. J.; Shevchenko, A.; et al. Segregation of 
Sphingolipids and Sterols during Formation of Secretory Vesicles at the Trans-Golgi 
Network. J. Cell Biol. 2009, 185 (4), 601–612. 
 
100 
 
Figures and Tables 
*1 s.d. < 0.1 
Table 4.1 Comparison of sphingolipid incorporation with respect to time 
  
Pulse-labeling time  
0.5 h 1 h 2 h 4 h 8 h 12 h 24 h 6 d 
Mean ± 1 s.d. (%) 
15
N-
incorporation in N-
palmitoyl sphingomyelin 
(LC-MS)  
8.6 ± 
6.2 
8.1 ± 
4.1 
7.7 ± 
0.0* 
13.5 
± 1.4 
19.9 
± 3.5 
27.5 
± 0.6 
36.5 
± 8.7 
88.5 
± 4.4 
Mean ± 1 s.d.  
15
N-
enrichment in plasma 
membrane (SIMS) 
2.4 ± 
0.5 
2.8 ± 
0.3 
4.0 ± 
1.0 
3.6 ± 
1.0 
6.0 ± 
1.3 
9.0 ± 
1.4 
7.6 ± 
1.3 
8.6 ± 
0.8 
Mean ± 1 s.d. 
15
N-
enrichment in sphingolipid 
domains (SIMS) 
6.9 ± 
2.0 
7.6 ± 
1.5 
9.1 ± 
2.2 
7.4 ± 
2.4 
10.9 
± 2.9 
17.2 
± 4.4 
14.1 
± 2.5 
19.7 
± 3.9 
Mean ± 1 s.d. 
15
N-
enrichment in non-domain 
areas (SIMS) 
2.2 ± 
0.4 
2.5 ± 
0.3 
3.4 ± 
0.7 
3.1 ± 
1.0 
5.1 ± 
1.6 
7.4 ± 
1.3 
6.6 ± 
1.5 
7.1 ± 
1.0 
Mean ± 1 s.d. (nm) 
effective domain diameter 
132 ± 
10 
137 ± 
5 
158 ± 
21 
149 ± 
16 
152 ± 
18 
168 ± 
21 
179 ± 
6.6 
171 ± 
11 
Mean ± 1 s.d. (%) surface 
coverage of 
15
N-
sphingolipid domains 
13.4 
± 3.7 
12.7 
± 3.1 
14.9 
± 1.4 
11.6 
± 3.2 
9.9 ± 
2.4 
12.0 
± 4.9 
14.3 
± 4.6 
15.1 
± 5.5 
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Figure 4.1  The 
15
N-enrichment images acquired with high-resolution SIMS at each pulse 
labeling time. Images revealed statistically significant domains of elevated 
15
N-sphingolipid after 
each pulse labeling time 
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Figure 4.2 Analysis of sphingolipid domain organization on the plasma membranes of cells 
isotopically labeled for varying lengths of time. (A) The average Ripley's K-test statistic, L(r) – 
r.  Lengths at which L(r) – r was larger than the 99% CI indicates non-random clustering over 
this distance; (B)  Plots of the average differences between the frequencies of observed and 
simulated nearest neighbor distances. A value larger than 0 indicates domains occurring more 
frequently than expected at that distance; (C) Plots of the average fractional difference in the 
observed and simulated pairwise domain distances. Values that deviate from 0 indicate domains 
occurring more frequently than expected at that distance. 
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CHAPTER 5. 
FINAL OBSERVATIONS, CONCLUSIONS, AND FUTURE OBJECTIVES 
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the U.S. DOE under contract DE-AC52-07NA27344. This material was supported in part by the 
National Science Foundation under CHE—1058809. 
  
104 
 
Final Observations 
 Clearly more studies must be performed to understand the complete role that vesicle 
traffic plays in the formation of sphingolipid domains. Initial work has been done using two 
types of disruption drugs: brefeldin A (BFA), which has been shown to halt trafficking at the 
Golgi apparatus;
1
  and nocodazole, which has been shown to depolymerize microtubules 
important for vesicle transport.
2
  
Methods and Materials 
The NIH3T3 mouse fibroblast cells were obtained from ATCC CRL-1658
TM
. Initial cell 
growth medium (Media A) consisted of high glucose Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10% Hyclone calf serum (Fisher Scientific), 10
4
 U/mL penicillin G, 
and 10 mg/mL streptomycin. During the second stage of cell growth, the medium (Media B) 
consisted of high glucose DMEM supplemented with 10% Hyclone lipid-reduced fetal bovine 
serum and 1% Hyclone calf serum (Fisher Scientific). A fatty acid solution (
13
C-fatty acids) 
made from algal lipid mixture (uniformly carbon-13 labeled, UL-
13
C, 98%+) (Cambridge Isotope 
Laboratories, Inc.), stearic acid (
13
C18, 99 atom% 
13
C) (Isotec), and fatty acid free bovine serum 
albumin (FAF-BSA) was used to metabolically label all cellular lipids as described in previous 
chapters. The 
15
N-sphingoid bases,
 
1:1 molar ratio of 
15
N-sphingosine and 
15
N-sphinganine, used 
to isotopically label sphingolipids were synthesized as detailed in previous chapters. Metabolic 
labeling was performed as described in previous chapters.  
Following metabolic labeling, cells were attached to silicon substrates (5 x 5 mm) (Ted 
Pella, Inc.) as described in previous chapters to enable sample analysis. Substrates with adherent 
cells were then divided into separate dishes functioning as either control or experimental 
treatments. One set of the sample substrates acted as controls and were placed in media 
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containing equal amounts of dimethyl sulfoxide as the experimental conditions. A second set of 
substrates was placed in media containing 10 µg/mL of nocodazole (Sigma) where they were 
incubated for 2 h before being removed and chemically fixed. The last set of substrates was 
placed in media containing 1 µg/mL of BFA (Biolegend) where they were incubated for 2 h 
before being removed and chemically fixed. 
Chemical fixation of the cells was performed with glutaraldehyde and osmium tetroxide 
(Electron Microscopy Sciences) as previously described. Lipid extraction followed by sample 
separation and mass spectrometry (MS) was performed as described in previous chapters using 
an Agilent 1100 LC/MSD Trap XCT Plus equipped with a Phenomenex Gemini 3u C6-Phenyl 
110A column (2 x 100 mm) (LC-MS) and an Agilent 6890 gas chromatograph with a ZB-WAX 
(30 m × 0.25 mm I.D., 0.25 m film thickness) capillary column (Phenomenex, Torrance, CA, 
USA), an Agilent 5973 mass selective detector and HP 7683B (Agilent Inc, Palo Alto, CA, 
USA) autosampler (GC-MS). 
Low voltage secondary electron microscopy (SEM) was performed on a Hitachi S-4800 
SEM followed by samples being imaged with Cameca’s NanoSIMS 50. Instrumental analysis 
and data analysis (including the use of L’Image and MATLAB) was performed as described in 
previous chapters. 
Results 
In these experiments, metabolically labeled  cells were exposed to one of the drug 
treatments prior to fixation and NanoSIMS analysis. Although treatment with BFA showed no 
noticeable changes in cell morphology (Fig. 5.1), NanoSIMS imaging showed marked changes 
in membrane sphingolipid distribution (Fig. 5.2). It appears there are fewer (if any) sphingolipid 
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domains on the cell’s surface. However, further experiments are required to confirm 
reproducibility of these results. 
Initial experiments were also performed to examine the defects of depolymerizing the 
microtubules that are required for vesicle transport using nocodazole. Metabolically labeled cells 
exposed to nocodazole showed very slight rounding (Fig. 5.3). This is presumably due to 
structural changes in the cellular cytoskeleton when the microtubules were depolymerized. The 
sphingolipid distribution appeared similar to what had been  observed in the BFA-treated cells 
(Fig. 5.4), specifically, lower sphingolipid content in the plasma membrane and fewer 
sphingolipid domains. This is consistent with the hypothesis that vesicle transport plays a role in 
sphingolipid organization  in the plasma membrane. However, further experiments are needed to 
confirm these preliminary results and elucidate their full meaning.  
Conclusions and Future Objectives 
 During the course of this work, we’ve established a protocol for using high resolution 
imaging secondary ion mass spectrometry (SIMS) to examine the distribution of specific lipid 
species in the plasma membranes of cells. Using this technique, we successfully visualized the 
locations of sphingolipids on the plasma membrane, and found that they are nonrandomly 
organized within domains.  We also explored the cause behind the formation of these 
sphingolipid domains. We found that the formation of these domains requires  an intact 
cytoskeleton, and  vesicle trafficking seems to be involved. 
The body of work described in Chapter 2 describes the technique development for using 
high resolution imaging SIMS to visualize sphingolipids in the plasma membranes of 
mammalian cells with a lateral resolution better than 100 nm. Precise incorporation of distinct 
isotope labels into plasma membrane components of interest, namely specific lipid species, 
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enables the direct analysis of their organization in the cell membrane. This facilitates answering 
questions related to membrane organization and its functional consequences, which have thus far 
evaded researchers. 
 Chapter 3 discussed the use of these high resolution SIMS techniques to evaluate the 
presence of sphingolipid domains on the cell surface. Use of the NanoSIMS confirmed a 
heterogeneous plasma membrane featuring regions with statistically significant local elevations 
of sphingolipids (domains) in comparison to the rest of the plasma membrane. These domains 
had an average diameter of 200 nm and were primarily organized in micron-sized clusters or 
patches. Disrupting the cytoskeleton of the cell resulted in the dispersal of these sphingolipid 
domains, implying that an intact cytoskeleton is necessary for the sphingolipid microdomains to 
be present. This set of studies has helped redefine our understanding of plasma membrane 
organization and has turned the tides in the “lipid raft”3 controversy4 by helping to disprove the 
concept.
5
 These studies also helped confirm the importance that an intact cytoskeleton plays in 
the formation of sphingolipid microdomains, and leads to the question of “What role does vesicle 
traffic play?” Our work in Chapter 4 and initial work in Chapter 5 has looked at this. 
 In an effort to visualize the vesicle trafficking of sphingolipids to the plasma membrane, 
a pulse-labeling experiment was performed in Chapter 4. This study showed rapid incorporation 
of isotope labels into the sphingolipids in the plasma membrane, indicating a very fast turnover 
rate. Statistically significant domains were detectable in the cells imaged after only 30 min of 
labeling. When comparing isotope incorporation in the bulk of the cell to that of the plasma 
membrane, it appears as though much of the newly synthesized sphingolipids are rapidly 
transported to the plasma membrane. This incorporation into the membrane was successfully 
visualized with the NanoSIMS. Also, at the beginning of this chapter we showed preliminary 
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results suggesting that the disruption of vesicle transport plays a role in the appearance of 
sphingolipids within domains. 
 Altogether, we developed a technique for using high resolution SIMS to study 
sphingolipids within the plasma membrane. This resulting technique then allowed steps to be 
taken towards determining how these sphingolipids form domains. An intact cytoskeleton 
appears to be essential. Results also suggest that vesicle trafficking of these sphingolipids to the 
membrane is done rapidly and may be essential to the formation of domains. More studies will 
be needed to understand the role of membrane transport on sphingolipid domain formation, but 
this technique can be combined with conventional biochemistry and biochemical methods to gain 
said knowledge. A drawback of these studies is that the drug treatments performed could have 
unknown effects on the cell and its membrane organization. Additional studies will need to 
address whether the observed sphingolipid organizations are a side effect of drug treatment, or if 
they are representative of the native cell function. Once the complete role of vesicle transport on 
sphingolipid domains is discovered we will have a more complete understanding of the 
formation of these sphingolipid domains on the plasma membrane; knowledge which will allow 
the scientific community to better control and manipulate the plasma membrane throughout its 
extensive interactions with its environment. 
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Figures 
 
Figure 5.1 Secondary electron image of a murine fibroblast cell disrupted with BFA. 
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Figure 5.2 
15
N-Enrichment image of a murine fibroblast cell disrupted with BFA. Sphingolipid 
abundance is lower, and the existence of sphingolipid domains is difficult to determine compared 
to previously analyzed non-drug treated cells. 
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Figure 5.3 Secondary electron image of a murine fibroblast cell disrupted with nocodazole. 
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Figure 5.4 
15
N-Enrichment image of a murine fibroblast cell disrupted with nocodazole. 
Sphingolipid abundance is lower, and the prevalence of sphingolipid domains appears to be 
lower than previously analyzed non-drug treated cells. 
 
 
